{"meta":{"query_hash":"a80a3a1c26f4","filters":{"venue":"ClinicoEconomics and Outcomes Research"},"cohort_total":83,"direct_labels_cover":2,"predictions_cover":83,"exported":83,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/a80a3a1c26f4","api":"https://metacan.xera.ac/api/v1/cohort?venue=ClinicoEconomics+and+Outcomes+Research"},"results":[{"id":"W1432569973","doi":"10.2147/ceor.s87462","title":"Acceptance of health technology assessment submissions with incremental cost-effectiveness ratios above the cost-effectiveness threshold","year":2015,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Institute for Health and Care Excellence","keywords":"Medicine; Cost effectiveness; Health technology; Data science; Computer science; Risk analysis (engineering); Health care; Economics","score_opus":0.6512456712451083,"score_gpt":0.6109980830969306,"score_spread":0.04024758814817775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1432569973","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08544525,0.3682692,0.060872413,0.15990151,0.047899965,0.076024786,0.060517713,0.0035301177,0.13753916],"genre_scores_gemma":[0.5791436,0.10578738,0.15866102,0.051679034,0.019660825,0.05186861,0.02372133,0.0013550634,0.008123188],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.43164065,0.24949442,0.18948904,0.011957114,0.11228466,0.0051341513],"domain_scores_gemma":[0.121441744,0.6272141,0.085811384,0.024159126,0.13725652,0.004117092],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.41306347,0.0025149481,0.0078586545,0.01741361,0.0017677273,0.014001093,0.0045060394,0.0068293638,0.010056033],"category_scores_gemma":[0.7852436,0.0015036673,0.017374542,0.01391315,0.002279839,0.008610287,0.0059515373,0.0083767725,0.002923982],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007841437,0.0003463555,0.032243185,0.33306158,0.024279034,0.0016131938,0.0058575077,0.004034856,0.0017024241,0.010892225,0.19635493,0.38177326],"study_design_scores_gemma":[0.00995753,0.0038916226,0.09932873,0.39045054,0.03977874,0.0025645809,0.0040773554,0.010221653,0.0045625404,0.038981028,0.39425695,0.0019287413],"about_ca_topic_score_codex":0.002970363,"about_ca_topic_score_gemma":0.0042621465,"teacher_disagreement_score":0.41306347,"about_ca_system_score_codex":0.00858137,"about_ca_system_score_gemma":0.022361143,"threshold_uncertainty_score":0.72379726},"labels":[],"label_agreement":null},{"id":"W1657561747","doi":"10.2147/ceor.s39624","title":"Do different clinical evidence bases lead to discordant health-technology assessment decisions? An in-depth case series across three jurisdictions","year":2013,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Eli Lilly and Company","keywords":"Nice; Medicine; Reimbursement; Listing (finance); Excellence; Health technology; Formulary; Family medicine; Clinical trial; Evidence-based medicine; Alternative medicine; Actuarial science; Health care; Business; Political science; Pathology","score_opus":0.7391213635127992,"score_gpt":0.6622200595753441,"score_spread":0.07690130393745509,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1657561747","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9171024,0.02388887,0.012109197,0.023347706,0.00036422326,0.0017863374,0.0003959126,0.00004504792,0.020960456],"genre_scores_gemma":[0.9813091,0.0045923996,0.008660043,0.0041489466,0.00015993851,0.00032196264,0.00012147376,0.000034008477,0.0006522035],"study_design_codex":"case_report","study_design_gemma":"qualitative","domain_scores_codex":[0.9285206,0.042629596,0.013777672,0.0029241599,0.00863123,0.0035166952],"domain_scores_gemma":[0.74331546,0.17841068,0.049032226,0.008203513,0.014099096,0.006939008],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.04700381,0.00070082536,0.0011857,0.0049084835,0.006779123,0.005313515,0.0024540585,0.006526567,0.0031078188],"category_scores_gemma":[0.19866754,0.0011894419,0.002110496,0.005917475,0.0042395154,0.0031761865,0.0061506974,0.0049090846,0.000359188],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054821634,0.0005881475,0.24594685,0.0031686027,0.000846846,0.63183784,0.04751011,0.0015940259,0.00074120425,0.015164977,0.005704418,0.046348736],"study_design_scores_gemma":[0.00031515496,0.0007981675,0.06328205,0.0103078345,0.0014128246,0.7687698,0.07442174,0.005234533,0.0032746375,0.0125063555,0.05930027,0.0003766616],"about_ca_topic_score_codex":0.010781445,"about_ca_topic_score_gemma":0.017673008,"teacher_disagreement_score":0.9529962,"about_ca_system_score_codex":0.010976698,"about_ca_system_score_gemma":0.008462166,"threshold_uncertainty_score":0.24858284},"labels":[],"label_agreement":null},{"id":"W1827447754","doi":"10.2147/ceor.s90386","title":"Bias within economic evaluations – the impact of considering the future entry of lower-cost generics on currently estimated incremental cost-effectiveness ratios of a new drug","year":2015,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada); Programs for Assessment of Technology in Health Research Institute; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Time horizon; Economic model; Cost–benefit analysis; Generic drug; Medicine; Cost effectiveness; Econometrics; Operations research; Actuarial science; Computer science; Economics; Mathematics; Mathematical optimization; Drug; Risk analysis (engineering); Pharmacology; Microeconomics","score_opus":0.7251800489594876,"score_gpt":0.6174641511457643,"score_spread":0.10771589781372337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1827447754","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.18170533,0.09344577,0.6444863,0.021169422,0.0033677854,0.0038819981,0.005137606,0.0009873653,0.045818426],"genre_scores_gemma":[0.93143934,0.005227171,0.055914115,0.0030342285,0.0004683072,0.0012359862,0.0007725419,0.00018194826,0.0017262318],"study_design_codex":"simulation_or_modeling","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.72424287,0.2225209,0.016520372,0.014243174,0.020158747,0.0023139855],"domain_scores_gemma":[0.21705455,0.7324874,0.027218705,0.015056035,0.0077720596,0.0004112872],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.3209316,0.0016989658,0.0032289035,0.0025610793,0.0005468764,0.006022968,0.003001696,0.0034520503,0.004129371],"category_scores_gemma":[0.6218425,0.0010357719,0.0068791504,0.0028208406,0.0029579634,0.0058929203,0.0027924282,0.004318662,0.0005167885],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009768706,0.00041616775,0.11510846,0.0127851,0.022475503,0.001526757,0.00095919846,0.3647312,0.0017793996,0.21479425,0.008648748,0.2470066],"study_design_scores_gemma":[0.0032003538,0.0033839114,0.061773118,0.010682677,0.015667558,0.002240119,0.0005418928,0.45869416,0.011595316,0.39210528,0.03938456,0.00073099206],"about_ca_topic_score_codex":0.0037687852,"about_ca_topic_score_gemma":0.002331496,"teacher_disagreement_score":0.6790684,"about_ca_system_score_codex":0.0070394124,"about_ca_system_score_gemma":0.004359314,"threshold_uncertainty_score":0.83741224},"labels":[],"label_agreement":null},{"id":"W1888218106","doi":"10.2147/ceor.s82549","title":"Evolution of health technology assessment: best practices of the pan-Canadian Oncology Drug Review","year":2015,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ciena (Canada)","funders":"","keywords":"Best practice; Stakeholder; Agency (philosophy); Medicine; Stakeholder engagement; Health care; Health technology; Public relations; Relevance (law); Medical education; Political science; Sociology","score_opus":0.7382198920775018,"score_gpt":0.6538015955181725,"score_spread":0.08441829655932931,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1888218106","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0125707565,0.12488681,0.053577147,0.6806201,0.0033592326,0.00276773,0.0007073785,0.000682042,0.120828815],"genre_scores_gemma":[0.5909447,0.09508481,0.22932394,0.06859657,0.0015295803,0.0020253824,0.0007399594,0.0005789753,0.011176038],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.50216913,0.2849984,0.035213295,0.02020677,0.14524965,0.012162753],"domain_scores_gemma":[0.34500885,0.21041621,0.027321752,0.034190156,0.3597749,0.02328812],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.3606582,0.0014120217,0.0020844669,0.023486778,0.016714983,0.04089291,0.010320897,0.0072552934,0.0020101957],"category_scores_gemma":[0.41495857,0.0018292215,0.001923516,0.026664974,0.034426622,0.0133504495,0.016266096,0.015607585,0.00072404253],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00015332189,0.0001795719,0.010933219,0.012398352,0.00045280042,0.00089766865,0.07598109,0.0041886964,0.00161313,0.26414475,0.11129261,0.5177648],"study_design_scores_gemma":[0.00006421334,0.00013209188,0.017103214,0.016475372,0.00018177832,0.00041007568,0.021465722,0.0025576707,0.0012717086,0.042010695,0.8978708,0.0004565668],"about_ca_topic_score_codex":0.85532695,"about_ca_topic_score_gemma":0.84250987,"teacher_disagreement_score":0.73711365,"about_ca_system_score_codex":0.26288635,"about_ca_system_score_gemma":0.52798855,"threshold_uncertainty_score":0.8549473},"labels":[],"label_agreement":null},{"id":"W1893993642","doi":"10.2147/ceor.s82194","title":"Nab-paclitaxel, docetaxel, or solvent-based paclitaxel in metastatic breast cancer: a cost-utility analysis from a Chinese health care perspective","year":2015,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Augmentium Pharma Consulting (Canada)","funders":"Celgene","keywords":"Paclitaxel; Docetaxel; Medicine; Metastatic breast cancer; Breast cancer; Oncology; Perspective (graphical); Cancer; Internal medicine","score_opus":0.18292777179286226,"score_gpt":0.5555170525744136,"score_spread":0.3725892807815514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1893993642","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9118774,0.062611334,0.010259961,0.0032997043,0.00013416747,0.0011785689,0.004627621,0.000050872724,0.0059604],"genre_scores_gemma":[0.9892452,0.0068413992,0.0018705137,0.0002724247,0.0000424988,0.00025198623,0.0010598525,0.000008722761,0.0004074144],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99608636,0.0028897503,0.00016554205,0.00026709068,0.00034195348,0.0002492733],"domain_scores_gemma":[0.996151,0.0029476325,0.00036906527,0.00009036522,0.0002781529,0.00016389939],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006633052,0.0012596018,0.0022799964,0.003995442,0.00031283824,0.0018118678,0.0011004348,0.00112297,0.0032536124],"category_scores_gemma":[0.012150529,0.00058229914,0.006841302,0.0037883106,0.00063066947,0.00091325125,0.00092521345,0.00095845433,0.000082629114],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018555816,0.00096396665,0.18090403,0.008368657,0.04024156,0.0026269862,0.00037045244,0.6171038,0.0015932687,0.010332104,0.004538348,0.11440104],"study_design_scores_gemma":[0.004858902,0.0064715305,0.16178837,0.0018739641,0.06000501,0.0012906083,0.0012105581,0.74137515,0.0011000714,0.01374991,0.005968176,0.00030772336],"about_ca_topic_score_codex":0.046317145,"about_ca_topic_score_gemma":0.024131307,"teacher_disagreement_score":0.046317145,"about_ca_system_score_codex":0.008885441,"about_ca_system_score_gemma":0.0058943955,"threshold_uncertainty_score":0.09209514},"labels":[],"label_agreement":null},{"id":"W1910786395","doi":"10.2147/ceor.s42649","title":"Follow-up analysis of federal process of care data reported from three acute care hospitals in rural Appalachia","year":2013,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Primary Care and Health Outcomes","field":"Health Professions","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pacific Centre for Reproductive Medicine","funders":"","keywords":"Medicaid; Medicine; Medical record; Acute care; Family medicine; Demography; Health care; Emergency medicine; Internal medicine","score_opus":0.1400537942355443,"score_gpt":0.5347350271289409,"score_spread":0.3946812328933966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1910786395","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994537,0.000017194488,0.000055347136,0.000013942355,8.134648e-7,0.000021149906,0.0002312824,0.000002336717,0.00020418271],"genre_scores_gemma":[0.9988098,0.000033027834,0.00019358294,0.000020325653,0.0000028231123,0.00006817093,0.00076848717,0.0000011307778,0.00010267894],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99833506,0.00038164028,0.00022297508,0.00020417933,0.00053760293,0.00031851526],"domain_scores_gemma":[0.9893049,0.001898078,0.0048318105,0.00046242168,0.0029250667,0.0005776717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015672804,0.00023992053,0.00022638665,0.0029687523,0.0009846832,0.0009277062,0.00041072816,0.00025106542,0.00057894114],"category_scores_gemma":[0.006429415,0.00016930595,0.00028974647,0.003051497,0.00050369673,0.00036458866,0.0011726617,0.00033661904,0.00012673462],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000034973884,0.00004264864,0.9963182,0.000015689515,0.00001977544,0.000085930915,0.0011567659,0.000058961643,0.00024235604,0.000012273792,0.00007941567,0.0019328244],"study_design_scores_gemma":[0.0000015295842,0.000057527654,0.99820673,0.0000052403284,0.0000058459195,0.000041731062,0.0013948359,0.00006724651,0.00009378428,0.0000033381739,0.00011961139,0.0000025974578],"about_ca_topic_score_codex":0.098139554,"about_ca_topic_score_gemma":0.16051303,"teacher_disagreement_score":0.098139554,"about_ca_system_score_codex":0.0023840363,"about_ca_system_score_gemma":0.0030634385,"threshold_uncertainty_score":0.19513667},"labels":[],"label_agreement":null},{"id":"W1973529506","doi":"10.2147/ceor.s33444","title":"Cost-effectiveness analysis of intranasal live attenuated vaccine (LAIV) versus injectable inactivated influenza vaccine (TIV) for Canadian children and adolescents","year":2012,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; St. Joseph’s Healthcare Hamilton; Programs for Assessment of Technology in Health Research Institute","funders":"Ontario Ministry of Health and Long-Term Care; AstraZeneca Canada; AstraZeneca","keywords":"Live attenuated influenza vaccine; Medicine; Vaccination; Pediatrics; Influenza vaccine; Immunology","score_opus":0.17969868565364,"score_gpt":0.486553965957672,"score_spread":0.306855280304032,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973529506","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9398434,0.021516552,0.0035953203,0.003151866,0.00017793263,0.0016882769,0.015057971,0.00011364894,0.014855009],"genre_scores_gemma":[0.9917487,0.00300626,0.0020407836,0.00021059968,0.000020266938,0.00021205274,0.001919886,0.000011595682,0.0008299541],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9978027,0.0010864929,0.000091267786,0.00016754855,0.0003991941,0.00045286666],"domain_scores_gemma":[0.99679047,0.0016227656,0.0003781418,0.000056094697,0.00061855273,0.0005339539],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037215936,0.0016265924,0.0020482838,0.0014083225,0.00073835993,0.0015537366,0.0020227877,0.0010578643,0.003801434],"category_scores_gemma":[0.010263593,0.00060687715,0.0041629556,0.0015273999,0.0005751317,0.00053849147,0.00074033067,0.001261801,0.000121069366],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.032631505,0.0009193579,0.066730425,0.0049842126,0.012225871,0.000500747,0.0002419709,0.8103992,0.0011635057,0.0070238207,0.0078951735,0.05528421],"study_design_scores_gemma":[0.014766923,0.00952795,0.16776386,0.0020705983,0.024892718,0.00050095003,0.0008412015,0.76720697,0.0014811913,0.0030376725,0.0075876163,0.00032241922],"about_ca_topic_score_codex":0.92453647,"about_ca_topic_score_gemma":0.89005035,"teacher_disagreement_score":0.07546353,"about_ca_system_score_codex":0.07343934,"about_ca_system_score_gemma":0.043840893,"threshold_uncertainty_score":0.53284216},"labels":[],"label_agreement":null},{"id":"W1997613802","doi":"10.2147/ceor.s30547","title":"Impact of screening and early detection of impaired fasting glucose tolerance and type 2 diabetes in Canada: a Markov model simulation","year":2012,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Public Health Agency of Canada","funders":"Public Health Agency; Public Health Agency of Canada","keywords":"Prediabetes; Medicine; Impaired fasting glucose; Type 2 diabetes; Type 2 Diabetes Mellitus; Diabetes mellitus; Impaired glucose tolerance; Asymptomatic; Internal medicine; Endocrinology","score_opus":0.06121437795526665,"score_gpt":0.3701620616856872,"score_spread":0.3089476837304206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997613802","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97108287,0.0005993977,0.00782312,0.002103795,0.00007616767,0.0003916368,0.0045732385,0.00010842088,0.013241342],"genre_scores_gemma":[0.9914487,0.00036083904,0.0029978724,0.00021592884,0.000014794327,0.00018658965,0.0013090173,0.00001370443,0.0034525394],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9988293,0.00045173842,0.000031001,0.00013529115,0.00010091149,0.00045182114],"domain_scores_gemma":[0.99051535,0.0067264037,0.00057446636,0.00020432689,0.0011794453,0.00080000417],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023032934,0.0013330964,0.0016016457,0.001303975,0.001715841,0.0016863958,0.0024078635,0.0024085108,0.006500677],"category_scores_gemma":[0.009539519,0.00081892486,0.0021689753,0.0015687712,0.001474935,0.00085065485,0.0011744731,0.0017933275,0.0002513818],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005565694,0.00017098869,0.008048415,0.000041250973,0.00009679721,0.00009827176,0.000035255744,0.9859753,0.00007549294,0.002730269,0.000969441,0.0012019869],"study_design_scores_gemma":[0.00047534893,0.00015978582,0.0032634474,0.000024380292,0.00011044917,0.00002319087,0.000088115135,0.9941485,0.00007063659,0.0012141679,0.00039179632,0.000030240395],"about_ca_topic_score_codex":0.89238375,"about_ca_topic_score_gemma":0.74978167,"teacher_disagreement_score":0.107616246,"about_ca_system_score_codex":0.022901835,"about_ca_system_score_gemma":0.021286776,"threshold_uncertainty_score":0.21649998},"labels":[],"label_agreement":null},{"id":"W1998206968","doi":"10.2147/ceor.s78115","title":"Incorporating ulipristal acetate in the care of symptomatic uterine fibroids: a Canadian cost-utility analysis of pharmacotherapy management","year":2015,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Uterine Myomas and Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University of Ottawa; Oakville Public Library; University of Toronto; McMaster University; St. Joseph’s Healthcare Hamilton; Programs for Assessment of Technology in Health Research Institute","funders":"","keywords":"Ulipristal acetate; Medicine; Uterine fibroids; Gynecology; Internal medicine; Family planning; Population; Environmental health","score_opus":0.11901442888560035,"score_gpt":0.4712039561897308,"score_spread":0.35218952730413045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998206968","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.79457605,0.045698915,0.04303961,0.0153593905,0.00032415,0.0048772343,0.022722691,0.0002604062,0.07314155],"genre_scores_gemma":[0.9795349,0.005365468,0.010251642,0.00051986444,0.000035724614,0.00031334767,0.0023126171,0.000027135302,0.0016392524],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.99474573,0.0030311262,0.00015463446,0.00026575796,0.0012042386,0.00059855054],"domain_scores_gemma":[0.993873,0.0038406441,0.00043352242,0.00013676092,0.0013059671,0.00041007597],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0064779404,0.0017743296,0.0018469115,0.0026303001,0.0011894873,0.0029308454,0.0020597705,0.0015168822,0.003727282],"category_scores_gemma":[0.021391243,0.00078913546,0.004138773,0.003718042,0.0008623337,0.00089740864,0.0010476281,0.0017419137,0.00013219341],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003951652,0.00035216086,0.01852927,0.0016684455,0.0024262618,0.00031354887,0.000120756544,0.91160446,0.0005992292,0.014213585,0.005345068,0.04087551],"study_design_scores_gemma":[0.0021140894,0.0013736971,0.028699648,0.00069144944,0.0033755356,0.00026680488,0.00025312617,0.94751585,0.0003825997,0.0057456223,0.009398624,0.00018299758],"about_ca_topic_score_codex":0.9198462,"about_ca_topic_score_gemma":0.84530467,"teacher_disagreement_score":0.08015382,"about_ca_system_score_codex":0.06415848,"about_ca_system_score_gemma":0.05221325,"threshold_uncertainty_score":0.46550453},"labels":[],"label_agreement":null},{"id":"W2004742061","doi":"10.2147/ceor.s51052","title":"Cost-effectiveness of ticagrelor versus clopidogrel in patients with acute coronary syndromes in Canada","year":2014,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Michael's Hospital; University of Toronto; University Health Network; St. Paul's Hospital; McMaster University; Programs for Assessment of Technology in Health Research Institute; St. Joseph’s Healthcare Hamilton; AstraZeneca (Canada); University of Alberta Hospital; Alberta Hospital Edmonton","funders":"University of Toronto; Heart and Stroke Foundation of Canada","keywords":"Ticagrelor; Clopidogrel; Medicine; Acute coronary syndrome; Cardiology; Internal medicine; Aspirin; Intensive care medicine; Myocardial infarction","score_opus":0.06132080415009829,"score_gpt":0.37724270325244,"score_spread":0.31592189910234175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004742061","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9656257,0.0073050135,0.0015318317,0.006011998,0.00006416976,0.00043581263,0.005258807,0.000047767477,0.013718922],"genre_scores_gemma":[0.9972402,0.00093077886,0.0005076552,0.00020033642,0.000008348792,0.000033669963,0.0006555252,0.000003965133,0.0004196908],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9984427,0.0005298601,0.00006689368,0.000114536204,0.0004025512,0.00044349371],"domain_scores_gemma":[0.9971642,0.0012181419,0.0003911941,0.00005189827,0.00072704285,0.0004475558],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018770018,0.0005136078,0.0006694634,0.00084366713,0.00094522134,0.0015419752,0.0012186668,0.00066414656,0.0026662634],"category_scores_gemma":[0.009580117,0.00031192304,0.0013771442,0.0012865799,0.0006432079,0.0004707777,0.0007632032,0.00085960224,0.000079140234],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013101323,0.00085039827,0.2941676,0.001789958,0.00439487,0.0010045802,0.0005219542,0.5751003,0.0011763783,0.015443196,0.013637556,0.07881193],"study_design_scores_gemma":[0.003998557,0.0019288332,0.2882318,0.0010260396,0.0036085662,0.0005512843,0.0013808229,0.6811321,0.0011849044,0.009127862,0.007589375,0.00023994419],"about_ca_topic_score_codex":0.95598185,"about_ca_topic_score_gemma":0.94990027,"teacher_disagreement_score":0.074653745,"about_ca_system_score_codex":0.074653745,"about_ca_system_score_gemma":0.05471483,"threshold_uncertainty_score":0.5416534},"labels":[],"label_agreement":null},{"id":"W2007548426","doi":"10.2147/ceor.s63187","title":"Conversion of the Seattle Angina Questionnaire into EQ-5D utilities for ischemic heart disease: a systematic review and catalog of the literature","year":2014,"lang":"en","type":"review","venue":"ClinicoEconomics and Outcomes Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Centre hospitalier universitaire de Québec; St. Michael's Hospital","funders":"Heart and Stroke Foundation of Canada","keywords":"Medicine; Angina; EQ-5D; Cochrane Library; Revascularization; Quality of life (healthcare); Coronary artery disease; MEDLINE; Bypass grafting; Internal medicine; Disease; Physical therapy; Meta-analysis; Artery; Health related quality of life; Myocardial infarction","score_opus":0.42344563812516706,"score_gpt":0.531508440018112,"score_spread":0.10806280189294498,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007548426","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001388511,0.99501365,0.0006671212,0.00037208622,0.000120638,0.0010172626,0.0010534307,0.000022641327,0.00034461234],"genre_scores_gemma":[0.016406376,0.97610813,0.0035191667,0.0005935718,0.0000886104,0.0024144796,0.00070961367,0.000015704516,0.00014436634],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9811748,0.005509831,0.008544986,0.001237827,0.003206996,0.0003255831],"domain_scores_gemma":[0.93177444,0.047989253,0.011785281,0.0011535024,0.006953495,0.0003440464],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.023457807,0.0020604695,0.0093222475,0.03895886,0.0009371901,0.0034932452,0.0025055374,0.0016858758,0.0038495043],"category_scores_gemma":[0.09611071,0.0014782887,0.0104742395,0.032235965,0.0012069443,0.003966857,0.0023716774,0.0012035731,0.00042579122],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000107475724,0.000014800444,0.001734916,0.93142724,0.006654181,0.00010525803,0.00029987795,0.00015225683,0.00012966432,0.00035005063,0.0020978604,0.056926437],"study_design_scores_gemma":[0.00015496688,0.00013194293,0.0054860795,0.94059354,0.039107993,0.0004017075,0.00035583932,0.00018719138,0.00016649449,0.00044296935,0.012919933,0.00005136969],"about_ca_topic_score_codex":0.008984792,"about_ca_topic_score_gemma":0.024624052,"teacher_disagreement_score":0.9765422,"about_ca_system_score_codex":0.006278197,"about_ca_system_score_gemma":0.01576603,"threshold_uncertainty_score":0.12405825},"labels":[],"label_agreement":null},{"id":"W2010903473","doi":"10.2147/ceor.s16675","title":"Cost considerations in the management of atrial fibrillation – impact of dronedarone","year":2012,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Southlake Regional Health Center","funders":"","keywords":"Dronedarone; Medicine; Atrial fibrillation; Management of atrial fibrillation; Cardiology; Intensive care medicine; Internal medicine; Amiodarone","score_opus":0.36286953161102875,"score_gpt":0.5422575221405838,"score_spread":0.179387990529555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010903473","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.108834475,0.40116996,0.010480458,0.37626132,0.0023325349,0.00026567513,0.0009980919,0.000057948888,0.09959963],"genre_scores_gemma":[0.79058146,0.17533937,0.008100534,0.015194988,0.0039851316,0.00017825473,0.00039214003,0.000031007476,0.006197047],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9974535,0.0014608542,0.00018668249,0.000088204186,0.0006455332,0.00016521654],"domain_scores_gemma":[0.99407864,0.0038617237,0.0006691756,0.00005095164,0.0009303608,0.00040909825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030789888,0.0004446562,0.00059715856,0.0011227801,0.000428166,0.0029925145,0.00062560715,0.001807732,0.0067595793],"category_scores_gemma":[0.013691178,0.00016769064,0.0007642807,0.0009923937,0.00057388295,0.0016392291,0.0011443506,0.0019589532,0.00032760427],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022534314,0.00039896794,0.02000684,0.0033182262,0.00088509655,0.0028713928,0.00037758035,0.028855292,0.0019873912,0.10680873,0.046059974,0.78617704],"study_design_scores_gemma":[0.0021862336,0.0040231706,0.14618619,0.021221416,0.0031116444,0.019535918,0.0071343286,0.048295997,0.004516669,0.21613969,0.5272134,0.00043545986],"about_ca_topic_score_codex":0.006692303,"about_ca_topic_score_gemma":0.008051432,"teacher_disagreement_score":0.0067595793,"about_ca_system_score_codex":0.0043163886,"about_ca_system_score_gemma":0.0039933417,"threshold_uncertainty_score":0.03131777},"labels":[],"label_agreement":null},{"id":"W2014266678","doi":"10.2147/ceor.s66309","title":"Oncology drug health technology assessment recommendations: Canadian versus UK experiences","year":2014,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Alternative medicine; Drug; Family medicine; Data science; Bioinformatics; Pharmacology; Pathology; Biology; Computer science","score_opus":0.6008255346384248,"score_gpt":0.63700972465046,"score_spread":0.03618419001203521,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014266678","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09357651,0.21182308,0.0027339566,0.52000815,0.0025937213,0.0015161887,0.009539289,0.00019327996,0.15801588],"genre_scores_gemma":[0.75078076,0.13444322,0.014909293,0.0850297,0.0011813651,0.00077520235,0.0041249464,0.00020759196,0.00854785],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.87439615,0.04010209,0.018159768,0.005841745,0.05357209,0.007928087],"domain_scores_gemma":[0.49031436,0.22528507,0.043126862,0.008073084,0.20175283,0.03144775],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.093326986,0.00045038364,0.0008190434,0.0076671187,0.0034477324,0.010345835,0.00275744,0.0043645906,0.0043497505],"category_scores_gemma":[0.38371858,0.0007141267,0.001115824,0.024164446,0.0034687154,0.004078473,0.003695424,0.0045443643,0.00039911055],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012057478,0.00026413435,0.095799215,0.018376209,0.0006087708,0.0010918943,0.031843215,0.001618686,0.0005509358,0.034943502,0.30981523,0.5038825],"study_design_scores_gemma":[0.00033709226,0.00039120732,0.15317193,0.029760959,0.0005681636,0.0010248874,0.018641837,0.001172278,0.0005259405,0.0024192396,0.79160744,0.0003791068],"about_ca_topic_score_codex":0.88926506,"about_ca_topic_score_gemma":0.89255476,"teacher_disagreement_score":0.906673,"about_ca_system_score_codex":0.10322575,"about_ca_system_score_gemma":0.23021017,"threshold_uncertainty_score":0.74895877},"labels":[],"label_agreement":null},{"id":"W2025067392","doi":"10.2147/ceor.s77175","title":"Inpatient cost of treating osteoporotic fractures in mainland China: a descriptive analysis","year":2015,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Bone health and osteoporosis research","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"inVentiv Health Clinical","funders":"Peking Union Medical College Hospital; Eli Lilly and Company","keywords":"Medicine; Osteoporosis; Hip fracture; Incidence (geometry); Diagnosis code; Emergency medicine; Mainland China; Population; Pediatrics; Demography; Physical therapy; China; Internal medicine; Environmental health","score_opus":0.12633890261137964,"score_gpt":0.4744187474882849,"score_spread":0.34807984487690524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025067392","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99841917,0.00015035788,0.00004093652,0.00003066369,0.0000015330369,0.0000088811685,0.0011349501,0.0000024679405,0.00021097763],"genre_scores_gemma":[0.99795496,0.00013648714,0.000055284167,0.000017472701,0.0000055257206,0.000015229093,0.0017135697,9.3476245e-7,0.0001005379],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996563,0.00003748346,0.00008117433,0.000051039526,0.00011216607,0.00006187809],"domain_scores_gemma":[0.99908185,0.00014333967,0.0005031763,0.000038613398,0.00013253377,0.00010043933],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037019828,0.00024249603,0.00030230862,0.0021252371,0.00024292737,0.00039420283,0.0003901238,0.0001994066,0.00091456925],"category_scores_gemma":[0.0009970284,0.00018663977,0.0006664314,0.0020013133,0.00016790294,0.0004186416,0.00031647613,0.00022421191,0.000076244265],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003455519,0.000023166489,0.9979614,0.000020314683,0.00005929965,0.00006816826,0.000042979937,0.00020440583,0.0000444491,0.000019230783,0.00013152401,0.001390492],"study_design_scores_gemma":[0.000002351758,0.000017101811,0.99917334,0.0000040792997,0.000014188003,0.00007067126,0.00008751822,0.00053588435,0.00001818618,0.000009637059,0.00006468427,0.0000021991864],"about_ca_topic_score_codex":0.027751729,"about_ca_topic_score_gemma":0.032872375,"teacher_disagreement_score":0.027751729,"about_ca_system_score_codex":0.001326009,"about_ca_system_score_gemma":0.00091649964,"threshold_uncertainty_score":0.05518043},"labels":[],"label_agreement":null},{"id":"W2029722120","doi":"10.2147/ceor.s14404","title":"Transferability of health technology assessments and economic evaluations: a systematic review of approaches for assessment and application","year":2011,"lang":"en","type":"review","venue":"ClinicoEconomics and Outcomes Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":131,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; St. Joseph’s Healthcare Hamilton; Programs for Assessment of Technology in Health Research Institute","funders":"Ontario Ministry of Health and Long-Term Care","keywords":"Transferability; Checklist; Computer science; Data science; Health care; Medicine; Management science; Machine learning; Psychology; Engineering","score_opus":0.8234713682036561,"score_gpt":0.6793536527463534,"score_spread":0.14411771545730268,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029722120","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00081951614,0.98796123,0.0042333403,0.0019885849,0.00046229377,0.0032422168,0.00035762353,0.000036771162,0.00089839054],"genre_scores_gemma":[0.032095708,0.92974734,0.02351186,0.0016285437,0.00034609984,0.012057524,0.00043330528,0.000045416953,0.00013414252],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.500923,0.2938612,0.12572554,0.011812337,0.06559883,0.0020790931],"domain_scores_gemma":[0.18986756,0.7128775,0.052661873,0.010676588,0.032908462,0.0010079736],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.34046555,0.0037958745,0.014412107,0.05446119,0.0027594902,0.015433179,0.0063095796,0.00576897,0.0040931418],"category_scores_gemma":[0.7060117,0.0039984924,0.017672272,0.04498884,0.0067269136,0.017693618,0.008721702,0.007415937,0.00052101066],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023413464,0.00005246488,0.0013143291,0.82924986,0.009155078,0.00006698007,0.0012269742,0.0005252137,0.00008237818,0.0036315357,0.0018412111,0.15261978],"study_design_scores_gemma":[0.00020522789,0.00011313976,0.00154886,0.971316,0.012973395,0.000109239736,0.0005625135,0.0004057659,0.00015210427,0.0025972116,0.0099519575,0.00006457979],"about_ca_topic_score_codex":0.0109696295,"about_ca_topic_score_gemma":0.019390699,"teacher_disagreement_score":0.65953445,"about_ca_system_score_codex":0.030336991,"about_ca_system_score_gemma":0.06347533,"threshold_uncertainty_score":0.8133234},"labels":[],"label_agreement":null},{"id":"W2031300497","doi":"10.2147/ceor.s24192","title":"Health status, hospitalizations, day procedures, and physician costs associated with body mass index (BMI) levels in Ontario, Canada","year":2012,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Obesity and Health Practices","field":"Health Professions","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; McMaster University; University of Alberta; St. Joseph’s Healthcare Hamilton; Programs for Assessment of Technology in Health Research Institute","funders":"Pfizer Canada; Ontario Ministry of Health and Long-Term Care; Pfizer","keywords":"Medicine; Underweight; Overweight; Body mass index; Obesity; Medical record; Public health; Gerontology; Demography; Environmental health; Internal medicine","score_opus":0.1073500015138216,"score_gpt":0.48651171518872527,"score_spread":0.3791617136749037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031300497","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97139156,0.002520482,0.00012123035,0.0013251672,0.000026648351,0.000085102656,0.018350013,0.000027167831,0.0061527994],"genre_scores_gemma":[0.99217707,0.0012344474,0.0001992828,0.00014018983,0.00001017227,0.00003117459,0.0043489523,0.000006963186,0.0018516984],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992067,0.000039744704,0.000058472717,0.000073355906,0.00032495052,0.0002967273],"domain_scores_gemma":[0.9974686,0.000110497116,0.0006120575,0.00004045003,0.0010065065,0.00076192705],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036366808,0.00028482842,0.00031054596,0.0012623294,0.0021685977,0.0008848141,0.0009172422,0.0002777623,0.003242135],"category_scores_gemma":[0.00176254,0.00028569682,0.0005184085,0.0039458396,0.0005095685,0.00023940798,0.0007094652,0.00048737746,0.00020711664],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009127494,0.000027685212,0.9903458,0.000094278985,0.00004900827,0.00011436854,0.00050463737,0.0001540474,0.00011954896,0.00007793167,0.003907053,0.004514419],"study_design_scores_gemma":[0.0000056666963,0.000008178515,0.99882084,0.000030396373,0.000012720906,0.000025711644,0.00031961375,0.000113811366,0.000012465633,0.000008395522,0.000637812,0.00000432293],"about_ca_topic_score_codex":0.9980767,"about_ca_topic_score_gemma":0.99887043,"teacher_disagreement_score":0.036255144,"about_ca_system_score_codex":0.036255144,"about_ca_system_score_gemma":0.042527456,"threshold_uncertainty_score":0.26305073},"labels":[],"label_agreement":null},{"id":"W2032696995","doi":"10.2147/ceor.s33390","title":"Economic analysis of Heart and Stroke Foundation of Ontario's Hypertension Management Initiative","year":2012,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Blood Pressure and Hypertension Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute for Clinical Evaluative Sciences; University Health Network; University of Toronto; Heart and Stroke Foundation; Sunnybrook Health Science Centre; Toronto Public Health; Health Sciences Centre","funders":"University of Toronto; Ontario Ministry of Health and Long-Term Care; Institute for Clinical Evaluative Sciences; Canada Research Chairs; Heart and Stroke Foundation of Canada","keywords":"Medicine; Life expectancy; Cohort; Framingham Risk Score; Health care; Stroke (engine); Blood pressure; Emergency medicine; Cohort study; Disease; Gerontology; Population; Internal medicine; Environmental health","score_opus":0.2059208196476358,"score_gpt":0.4375019505193778,"score_spread":0.23158113087174198,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032696995","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8935654,0.020906964,0.006057009,0.008116587,0.0001864086,0.0022846414,0.03340662,0.000069166155,0.035407297],"genre_scores_gemma":[0.9903024,0.001690172,0.0018542889,0.00024715433,0.00003488363,0.00032337537,0.004507168,0.000006783227,0.001033932],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9958561,0.0026134595,0.00015345798,0.00016113208,0.0007352416,0.00048056865],"domain_scores_gemma":[0.99609464,0.0020487376,0.0005105432,0.00014918736,0.00078810484,0.00040878018],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006644439,0.00067707617,0.0009832404,0.001309912,0.00046654776,0.0012984087,0.0007967375,0.00056258467,0.0024973406],"category_scores_gemma":[0.01497729,0.00032842203,0.001774012,0.0016801155,0.00042379505,0.0005255072,0.0007756848,0.0007079007,0.0000828366],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023519758,0.001968237,0.36394686,0.0076122675,0.01256676,0.0007124947,0.00054809765,0.33087984,0.0005858469,0.03710044,0.049222283,0.17133711],"study_design_scores_gemma":[0.007120825,0.0059354804,0.54959214,0.0023021745,0.009286709,0.0005594647,0.0010449889,0.3731312,0.00068633066,0.011651553,0.038466696,0.00022254423],"about_ca_topic_score_codex":0.3353858,"about_ca_topic_score_gemma":0.33147508,"teacher_disagreement_score":0.3353858,"about_ca_system_score_codex":0.02141108,"about_ca_system_score_gemma":0.011974422,"threshold_uncertainty_score":0.66686726},"labels":[],"label_agreement":null},{"id":"W2048536877","doi":"10.2147/ceor.s65900","title":"Clinical response and hospital costs associated with the empirical use of vancomycin and linezolid for hospital-acquired pneumonia in a Chinese tertiary care hospital: a retrospective cohort study","year":2014,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Nosocomial Infections in ICU","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada); Public Health Ontario; University of Toronto","funders":"Eli Lilly and Company","keywords":"Medicine; Vancomycin; Propensity score matching; Linezolid; Odds ratio; Retrospective cohort study; Pneumonia; Internal medicine; Intensive care medicine; Emergency medicine; Staphylococcus aureus","score_opus":0.06662898276258017,"score_gpt":0.45105435848140235,"score_spread":0.3844253757188222,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048536877","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99965715,0.00008475843,0.00002857212,0.00001713313,0.0000028973216,0.000012910486,0.00013327801,7.879496e-7,0.00006253218],"genre_scores_gemma":[0.99954504,0.00005040312,0.00003799623,0.000024458624,0.0000068997665,0.000016310276,0.00027542602,7.6391046e-7,0.000042633375],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987532,0.00017957608,0.00022276022,0.00034457093,0.0002554402,0.00024445087],"domain_scores_gemma":[0.99796826,0.00015200746,0.001049466,0.00021184121,0.00023239836,0.0003861274],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011198923,0.00044939274,0.0006069576,0.0011431598,0.00074681675,0.000694327,0.0006604654,0.0005432529,0.00095912436],"category_scores_gemma":[0.0022161945,0.0005176335,0.0009974977,0.0017303812,0.0004856354,0.0005872703,0.0007365443,0.0005540517,0.00010274115],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006193156,0.000021946249,0.99937767,0.0000070158076,0.00006823994,0.00007959264,0.00004942618,0.000021047936,0.00005782988,0.000008118085,0.0000329434,0.00021418973],"study_design_scores_gemma":[0.00001182455,0.00007852888,0.9991435,0.000004680722,0.000054462173,0.00021013213,0.00019750708,0.0001861925,0.00003488282,0.00001275567,0.000060519265,0.0000051524294],"about_ca_topic_score_codex":0.015968224,"about_ca_topic_score_gemma":0.015453436,"teacher_disagreement_score":0.015968224,"about_ca_system_score_codex":0.0014483429,"about_ca_system_score_gemma":0.0016722112,"threshold_uncertainty_score":0.03175056},"labels":[],"label_agreement":null},{"id":"W2055992137","doi":"10.2147/ceor.s29347","title":"Two-factor theory – at the intersection of health care management and patient satisfaction","year":2012,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Customer Service Quality and Loyalty","field":"Business, Management and Accounting","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Logistic regression; Health care; Intersection (aeronautics); Behavioral Risk Factor Surveillance System; Job satisfaction; Factor (programming language); Psychology; Medicine; Applied psychology; Environmental health; Social psychology; Statistics; Nursing; Mathematics; Computer science; Public health; Engineering; Transport engineering","score_opus":0.09154446576835726,"score_gpt":0.4045769837691336,"score_spread":0.31303251800077636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055992137","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.311894,0.0013329363,0.6282572,0.005549986,0.00024687595,0.0027946595,0.0005882669,0.00022072636,0.049115278],"genre_scores_gemma":[0.9219009,0.00042137387,0.07406298,0.00032280432,0.00006814409,0.0016653022,0.00021425412,0.000013390487,0.0013308874],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.9875915,0.008040631,0.0004813356,0.00065302604,0.0028304844,0.00040309384],"domain_scores_gemma":[0.9830762,0.012905942,0.0013781227,0.00061330345,0.0016707128,0.00035566796],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011891826,0.0006692711,0.0007464582,0.003956501,0.00066593965,0.0025185128,0.00069296686,0.00069862476,0.0030353696],"category_scores_gemma":[0.02186879,0.00034152516,0.0015755713,0.0031249642,0.0028847628,0.0016668489,0.0015586651,0.0010991902,0.00026896116],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023041236,0.0006906892,0.21115854,0.00092733616,0.0004355605,0.00023825243,0.012061916,0.007917028,0.0008729539,0.50194955,0.0042971084,0.25922063],"study_design_scores_gemma":[0.00030165733,0.0014487645,0.27137688,0.0011330823,0.0002500157,0.00091116177,0.010089826,0.15255946,0.001250667,0.5336689,0.02681299,0.00019667142],"about_ca_topic_score_codex":0.0020645729,"about_ca_topic_score_gemma":0.0013225821,"teacher_disagreement_score":0.011891826,"about_ca_system_score_codex":0.0025043397,"about_ca_system_score_gemma":0.0035362276,"threshold_uncertainty_score":0.06289077},"labels":[],"label_agreement":null},{"id":"W2060950787","doi":"10.2147/ceor.s30857","title":"The economic impact of enoxaparin versus unfractionated heparin for prevention of venous thromboembolism in acute ischemic stroke patients","year":2012,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Heparin; Stroke (engine); Low molecular weight heparin; Intensive care medicine; Venous thromboembolism; Anticoagulant; Acute stroke; Emergency medicine; Internal medicine; Thrombosis","score_opus":0.07582140553644204,"score_gpt":0.46221919055001714,"score_spread":0.38639778501357513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060950787","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8925653,0.082763545,0.0007007932,0.007666731,0.00037502873,0.00021000912,0.0008743465,0.000006381269,0.014837796],"genre_scores_gemma":[0.98873305,0.009692028,0.0003356396,0.00042821118,0.00011870182,0.00003383385,0.00029626917,0.0000020592638,0.0003601971],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99728024,0.0018840566,0.00019702072,0.00006868883,0.00032142006,0.0002485194],"domain_scores_gemma":[0.9960448,0.0023847315,0.0008272748,0.000043916523,0.00030781035,0.00039145598],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024754838,0.00026641056,0.0005612056,0.0009593437,0.00020970085,0.001312442,0.0002752749,0.0003972608,0.0020679897],"category_scores_gemma":[0.01124086,0.000099507735,0.0012259567,0.0009028432,0.00026598544,0.00054672605,0.0006396491,0.0005788653,0.00007771184],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.088983074,0.0025881655,0.264884,0.0050846613,0.010035762,0.0023932806,0.00042519564,0.036494967,0.0020734924,0.017135926,0.008316694,0.5615847],"study_design_scores_gemma":[0.012180648,0.027595606,0.8121532,0.0045795934,0.02135433,0.0033978492,0.0034837187,0.06355245,0.0034120444,0.013125637,0.034861125,0.0003038207],"about_ca_topic_score_codex":0.0038034355,"about_ca_topic_score_gemma":0.0059443964,"teacher_disagreement_score":0.0038034355,"about_ca_system_score_codex":0.0026436988,"about_ca_system_score_gemma":0.0018094728,"threshold_uncertainty_score":0.01918149},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"design_other","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"split"},{"id":"W2091242733","doi":"10.2147/ceor.s31552","title":"Techniques for estimating health care costs with censored data: an overview for the health services researcher","year":2012,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":81,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Toronto Public Health; Health Sciences Centre; University of Toronto; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre","funders":"","keywords":"Estimator; Activity-based costing; Censoring (clinical trials); Medicine; Statistics; Health care; Health economics; Sample (material); Econometrics; Actuarial science; Mathematics; Economics; Public health; Business; Marketing; Nursing","score_opus":0.7588877606600927,"score_gpt":0.6583699927180167,"score_spread":0.10051776794207601,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091242733","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010917364,0.46140254,0.51262194,0.020245949,0.0015716933,0.0004953846,0.00036312288,0.00023010187,0.0019776372],"genre_scores_gemma":[0.020428218,0.51809835,0.44833642,0.0040062647,0.0058662673,0.0015858441,0.00046810115,0.00024158724,0.0009689486],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9150734,0.06198262,0.00669291,0.0024233435,0.013221061,0.0006066826],"domain_scores_gemma":[0.7328437,0.23592792,0.007235269,0.0063286866,0.017144797,0.0005195799],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.08295837,0.002750736,0.004437989,0.019665167,0.0009120864,0.0053014425,0.0056067547,0.00533918,0.0020179476],"category_scores_gemma":[0.21781342,0.0024030313,0.008072886,0.017883085,0.0062917857,0.009470761,0.0028625368,0.011342229,0.0011014888],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020272397,0.0003060442,0.009807468,0.016263036,0.0024569884,0.00027917672,0.001063277,0.025318922,0.00030565876,0.1602918,0.037199877,0.7465051],"study_design_scores_gemma":[0.00026361563,0.0007832195,0.014231402,0.030438673,0.0016599547,0.0019887956,0.0013831044,0.09332601,0.0014411068,0.5753817,0.27825308,0.0008493608],"about_ca_topic_score_codex":0.012676939,"about_ca_topic_score_gemma":0.006762124,"teacher_disagreement_score":0.08295837,"about_ca_system_score_codex":0.0067361533,"about_ca_system_score_gemma":0.007841798,"threshold_uncertainty_score":0.438731},"labels":[],"label_agreement":null},{"id":"W2094630798","doi":"10.2147/ceor.s37205","title":"Budget impact analysis of boceprevir and telaprevir for the treatment of hepatitis C genotype 1 infection","year":2012,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Hepatitis C virus research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Ottawa","funders":"","keywords":"Boceprevir; Telaprevir; Medicine; Ribavirin; Pegylated interferon; Internal medicine; Gastroenterology; Virology; Hepatitis C virus; Virus","score_opus":0.13712591260711343,"score_gpt":0.5096281915013214,"score_spread":0.372502278894208,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094630798","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8889321,0.011212927,0.049849313,0.0071306136,0.00027071993,0.0013120271,0.004404052,0.00017487232,0.036713343],"genre_scores_gemma":[0.99209255,0.0010393589,0.0042394656,0.00024356142,0.0000321947,0.00032186185,0.00070437725,0.000019784422,0.0013068902],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9953367,0.0035403986,0.00013569211,0.00016882955,0.00030015883,0.0005181262],"domain_scores_gemma":[0.98571855,0.011712546,0.00094170275,0.00019365227,0.0008070558,0.0006265069],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0069862776,0.0013511356,0.0016346128,0.0016932244,0.0005224168,0.0018134784,0.0011607226,0.0015398535,0.0065805446],"category_scores_gemma":[0.024757152,0.0010263929,0.002887234,0.0018359482,0.0006682608,0.002184017,0.0012294463,0.0021623261,0.00024916243],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014670899,0.00016295574,0.003901626,0.0002809164,0.00031588195,0.00017274439,0.000044343702,0.9806327,0.00016938415,0.005053268,0.0008739628,0.006925051],"study_design_scores_gemma":[0.0007725718,0.0009267746,0.007586036,0.00026890665,0.0007558889,0.00013532671,0.0002050875,0.9806445,0.0002821885,0.0064574652,0.00190233,0.0000628702],"about_ca_topic_score_codex":0.048700046,"about_ca_topic_score_gemma":0.02314242,"teacher_disagreement_score":0.048700046,"about_ca_system_score_codex":0.010599488,"about_ca_system_score_gemma":0.0062532094,"threshold_uncertainty_score":0.09683311},"labels":[],"label_agreement":null},{"id":"W2136904329","doi":"10.2147/ceor.s85635","title":"Review of the cost of venous thromboembolism","year":2015,"lang":"en","type":"review","venue":"ClinicoEconomics and Outcomes Research","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":171,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pulmonary embolism; Venous thromboembolism; Population; Emergency medicine; Incidence (geometry); MEDLINE; Total cost; Indirect costs; Intensive care medicine; Pediatrics; Surgery; Environmental health; Thrombosis","score_opus":0.28277643727394947,"score_gpt":0.5420026030179217,"score_spread":0.2592261657439722,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136904329","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00031849684,0.99796605,0.00006969901,0.0003960196,0.00018970728,0.00004552753,0.0003974496,0.000004171206,0.00061286753],"genre_scores_gemma":[0.0026400436,0.9966828,0.00015191798,0.00017127837,0.0000822775,0.000049944632,0.00014720549,0.0000025650577,0.00007193419],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99601126,0.0011774785,0.0012896957,0.00022160402,0.0011696677,0.00013035456],"domain_scores_gemma":[0.98699373,0.00896418,0.0021083148,0.00012915295,0.0016779738,0.00012664174],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033655728,0.0018396254,0.0052805897,0.012574796,0.00044203005,0.002741247,0.0016423559,0.0016310496,0.008909885],"category_scores_gemma":[0.024555944,0.0009529382,0.005114656,0.01684628,0.00046693953,0.0020297717,0.0009916036,0.0012818957,0.00066405005],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002642314,0.00003338311,0.0007926265,0.71794015,0.005167295,0.00018801914,0.0000797624,0.0006660697,0.000106600215,0.00170124,0.018762419,0.25429818],"study_design_scores_gemma":[0.00025178364,0.00022403114,0.007844493,0.8022326,0.027280612,0.001318608,0.0002340739,0.00034524244,0.00018199679,0.0019305097,0.15809597,0.00006006152],"about_ca_topic_score_codex":0.009769067,"about_ca_topic_score_gemma":0.014148981,"teacher_disagreement_score":0.012574796,"about_ca_system_score_codex":0.0053481977,"about_ca_system_score_gemma":0.0073238597,"threshold_uncertainty_score":0.038803995},"labels":[],"label_agreement":null},{"id":"W2147808981","doi":"10.2147/ceor.s61602","title":"Opioid-induced constipation in patients with chronic noncancer pain in the USA, Canada, Germany, and the UK: descriptive analysis of baseline patient-reported outcomes and retrospective chart review","year":2014,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Gastrointestinal motility and disorders","field":"Medicine","cited_by":114,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Laxative; Medicine; Constipation; Bloating; Defecation; Tegaserod; Irritable bowel syndrome; Cathartic; Medical prescription; Flatulence; Physical therapy; Internal medicine; Abdominal pain; Pharmacology","score_opus":0.03591146050078674,"score_gpt":0.34550008038958596,"score_spread":0.3095886198887992,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147808981","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99555874,0.0008474103,0.000035844823,0.000056729434,0.000004705765,0.00007585643,0.002763321,0.0000050751137,0.00065224327],"genre_scores_gemma":[0.9963379,0.00070455193,0.00010736753,0.0000784762,0.0000071368713,0.00006718145,0.002563587,0.000001959604,0.00013189137],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990428,0.00013886533,0.00016556078,0.000099526726,0.0003196223,0.00023359749],"domain_scores_gemma":[0.9970529,0.00042613616,0.0012772016,0.000059278897,0.00081720937,0.00036717948],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075353734,0.00020324685,0.0004982226,0.0022873592,0.0007404378,0.00075685035,0.00034143496,0.0003272107,0.0008928376],"category_scores_gemma":[0.0026911306,0.00019075641,0.0003575295,0.0044188523,0.00042487044,0.0003860533,0.0005977192,0.00029494026,0.00014314557],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006230183,0.000021212316,0.9980275,0.000032147123,0.000019793843,0.00011165507,0.00020315417,0.000013266697,0.000030251631,0.0000074874965,0.00022045616,0.0012506916],"study_design_scores_gemma":[0.000005284524,0.000055617526,0.9990013,0.000021590475,0.000011018684,0.00017803618,0.0004645687,0.00002432423,0.00001380048,0.0000020974487,0.00021829369,0.000004026255],"about_ca_topic_score_codex":0.39005926,"about_ca_topic_score_gemma":0.40128994,"teacher_disagreement_score":0.60994077,"about_ca_system_score_codex":0.003341614,"about_ca_system_score_gemma":0.004323048,"threshold_uncertainty_score":0.7755777},"labels":[],"label_agreement":null},{"id":"W2320400291","doi":"10.2147/ceor.s101013","title":"Designing economic evaluations to facilitate optimal decisions: the need to avoid bias","year":2016,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Canadian Agency for Drugs and Technologies in Health","funders":"","keywords":"Agency (philosophy); Argument (complex analysis); Economic evaluation; Actuarial science; External validity; Public economics; Medicine; Operations research; Positive economics; Economics; Sociology; Psychology; Social science; Microeconomics; Social psychology; Engineering","score_opus":0.8023725701622225,"score_gpt":0.5985496615594716,"score_spread":0.20382290860275087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2320400291","genre_codex":"methods","genre_gemma":"methods","domain_codex":"methods","domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":"methods","prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013128984,0.08435193,0.5479335,0.29214346,0.012294307,0.016815139,0.0012201994,0.0010209957,0.0310914],"genre_scores_gemma":[0.18560569,0.021689044,0.70900905,0.05615579,0.0072761346,0.017896345,0.00038349227,0.00040332344,0.0015811635],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.21845263,0.69706947,0.0437427,0.0053615877,0.03366356,0.0017099427],"domain_scores_gemma":[0.07796169,0.86752754,0.0170765,0.014533484,0.021393156,0.0015076632],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.63185346,0.0038968448,0.011504228,0.011197882,0.0027727569,0.01957482,0.0059416355,0.012439808,0.0062966947],"category_scores_gemma":[0.8641248,0.0025612337,0.0042662467,0.008075789,0.010013944,0.022775674,0.00753978,0.015045103,0.0024288334],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0057198866,0.00075669814,0.007523724,0.023181764,0.009025429,0.00063294236,0.005845757,0.024255797,0.0006825641,0.26702163,0.09031055,0.5650433],"study_design_scores_gemma":[0.0030258654,0.0009075337,0.002524164,0.024949107,0.0018716955,0.00037733663,0.0013587119,0.03340702,0.0013807337,0.85730374,0.0723605,0.0005336533],"about_ca_topic_score_codex":0.0025249596,"about_ca_topic_score_gemma":0.0027993065,"teacher_disagreement_score":0.36814654,"about_ca_system_score_codex":0.008927658,"about_ca_system_score_gemma":0.021444254,"threshold_uncertainty_score":0.45399028},"labels":[],"label_agreement":null},{"id":"W2346242965","doi":"10.2147/ceor.s104195","title":"Cost-effectiveness of bortezomib for multiple myeloma: a systematic review","year":2016,"lang":"en","type":"review","venue":"ClinicoEconomics and Outcomes Research","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Bortezomib; Multiple myeloma; Thalidomide; Lenalidomide; Cost effectiveness; Melphalan; Internal medicine; Oncology","score_opus":0.3310564834221789,"score_gpt":0.560687487546833,"score_spread":0.22963100412465404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2346242965","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009906209,0.9978362,0.000099101824,0.0002853154,0.00008032302,0.00013090226,0.00034005425,0.0000053466856,0.00023222803],"genre_scores_gemma":[0.022255078,0.9760383,0.0005087225,0.00049534335,0.00010641739,0.0002846582,0.00021651006,0.0000057108496,0.00008922816],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9949126,0.0020133858,0.0015126014,0.00034545953,0.001023673,0.00019222061],"domain_scores_gemma":[0.97982925,0.014973131,0.003318676,0.00016820541,0.0015272521,0.0001835276],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0056115924,0.0017035203,0.008482375,0.00807622,0.00044747858,0.0025604519,0.0016891918,0.0018938431,0.0049880785],"category_scores_gemma":[0.03375738,0.0010574426,0.010940506,0.008048385,0.0005427796,0.0017703495,0.000980935,0.0013698204,0.00022513559],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048159497,0.000027018054,0.0010275545,0.9248997,0.031151013,0.00009576075,0.00005350371,0.00038923536,0.00009891667,0.00035591278,0.0017726589,0.03964719],"study_design_scores_gemma":[0.0008106511,0.0003813788,0.0061841607,0.74651176,0.2269617,0.00055317045,0.00016244703,0.00043667373,0.00019119155,0.00078060245,0.016974553,0.00005166942],"about_ca_topic_score_codex":0.009759325,"about_ca_topic_score_gemma":0.020800706,"teacher_disagreement_score":0.009759325,"about_ca_system_score_codex":0.0048907357,"about_ca_system_score_gemma":0.007972242,"threshold_uncertainty_score":0.03548497},"labels":[],"label_agreement":null},{"id":"W2403025629","doi":"10.2147/ceor.s102243","title":"The changing landscape of antiviral treatment of herpes zoster: a 17-year population-based cohort study","year":2016,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Famciclovir; Rash; Medical prescription; Incidence (geometry); Population; Antiviral treatment; Antiviral therapy; Observational study; Shingles; Cohort; Pediatrics; Internal medicine; Immunology; Virus; Pharmacology; Environmental health","score_opus":0.060994089739721286,"score_gpt":0.424700146291634,"score_spread":0.3637060565519127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2403025629","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99573505,0.00036777527,0.00009353108,0.00018214993,0.000018261373,0.00003901842,0.0030778826,0.000004236494,0.00048207038],"genre_scores_gemma":[0.9970323,0.00039145208,0.00014106205,0.0001340331,0.000016850512,0.000047340705,0.0019475132,0.000005503286,0.00028399442],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99909306,0.00013946745,0.00007508895,0.00022503463,0.00020245422,0.00026495717],"domain_scores_gemma":[0.9984174,0.00007895171,0.0005373028,0.00015326307,0.00045508283,0.0003579584],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012642376,0.00038386715,0.0004931098,0.0010068489,0.0012590464,0.0012559108,0.0008885455,0.00071215315,0.001342266],"category_scores_gemma":[0.0022595183,0.0005991463,0.0009704835,0.0025723076,0.00034569026,0.0009349671,0.0009296661,0.0015605564,0.00031512338],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000311873,0.000029394818,0.9991109,0.0000051858765,0.000067862755,0.000047697802,0.0001230143,0.000013764164,0.000041123174,0.00001368969,0.00020769508,0.00030839205],"study_design_scores_gemma":[0.000008852795,0.000038318132,0.9988961,0.000013240422,0.000047416997,0.00011969524,0.00046058014,0.000117375654,0.000010338494,0.000012226251,0.00027035264,0.0000055565947],"about_ca_topic_score_codex":0.22025257,"about_ca_topic_score_gemma":0.23915984,"teacher_disagreement_score":0.22025257,"about_ca_system_score_codex":0.0018480635,"about_ca_system_score_gemma":0.0025831233,"threshold_uncertainty_score":0.43794113},"labels":[],"label_agreement":null},{"id":"W2419019628","doi":"10.2147/ceor.s105579","title":"Cost-effectiveness of tiotropium versus glycopyrronium in moderate to very severe chronic obstructive pulmonary disease in Canada, Spain, Sweden, and the UK","year":2016,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Boehringer Ingelheim (Canada)","funders":"","keywords":"Medicine; COPD; Tiotropium bromide; Lama; Bronchodilator; Obstructive lung disease; Cohort; Glycopyrrolate; Cost effectiveness; Clinical trial; Lung function; Physical therapy; Internal medicine; Intensive care medicine; Emergency medicine; Lung; Asthma","score_opus":0.05920928524898796,"score_gpt":0.37782531472878655,"score_spread":0.3186160294797986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2419019628","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9884067,0.0017658497,0.000970461,0.0015138506,0.000037112426,0.00019051762,0.003761298,0.000042389707,0.003311829],"genre_scores_gemma":[0.99709463,0.00041403173,0.00030586866,0.00014315665,0.0000049284185,0.000038289207,0.0013206338,0.0000054443735,0.0006730311],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.998747,0.00044776115,0.00004634286,0.00015691602,0.00016370942,0.00043833774],"domain_scores_gemma":[0.9965791,0.0017181834,0.0004024205,0.0000989146,0.00042414607,0.0007773124],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002682145,0.00075629115,0.0012177681,0.0006846886,0.0007015029,0.0020169357,0.0017032615,0.0013191716,0.0021795502],"category_scores_gemma":[0.009288952,0.0005086016,0.0018660635,0.0008879598,0.00083062105,0.0004898347,0.00119093,0.0010427242,0.00012289247],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006834668,0.0003761874,0.06635411,0.00031885196,0.0010989571,0.0005283815,0.00012033358,0.90605295,0.00038561173,0.005119655,0.003442728,0.009367431],"study_design_scores_gemma":[0.003210046,0.001662362,0.076940484,0.00040510768,0.0014612745,0.0003044352,0.0007842881,0.90854436,0.00074290356,0.0029410808,0.0028369299,0.00016676138],"about_ca_topic_score_codex":0.8920557,"about_ca_topic_score_gemma":0.7638986,"teacher_disagreement_score":0.10794431,"about_ca_system_score_codex":0.030332904,"about_ca_system_score_gemma":0.021748105,"threshold_uncertainty_score":0.22008169},"labels":[],"label_agreement":null},{"id":"W2517422947","doi":"10.2147/ceor.s96616","title":"Targeting improved patient outcomes using innovative product listing agreements: a survey of Canadian and international key opinion leaders","year":2016,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Global Affairs Canada; MaRS; University of Ottawa","funders":"","keywords":"Government (linguistics); Listing (finance); Medicine; Phone; Product (mathematics); Pharmacy; Health care; Griffin; Public relations; Political science; Library science; Family medicine; Business; Finance; Law","score_opus":0.6820703392903806,"score_gpt":0.5586353996660185,"score_spread":0.12343493962436214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2517422947","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9617936,0.00252376,0.00044940627,0.024281308,0.00018279956,0.0006617907,0.0017478833,0.00002383868,0.008335711],"genre_scores_gemma":[0.98274267,0.0026065353,0.0007142731,0.011660783,0.00008239508,0.0003419645,0.0004920162,0.00001840804,0.0013409625],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9893845,0.0028689199,0.0005348433,0.0005985547,0.003316093,0.0032970184],"domain_scores_gemma":[0.9628624,0.0069801114,0.0050369054,0.0004284604,0.01675039,0.007941773],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015776703,0.00028866314,0.00050867844,0.0018182652,0.00498217,0.002948175,0.0011701565,0.0015120202,0.002827556],"category_scores_gemma":[0.029766891,0.00037623776,0.0004718382,0.0023545397,0.0018824429,0.0012431495,0.0019209097,0.0020575037,0.00033198114],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047386508,0.00039321955,0.526927,0.0018015605,0.00009474233,0.0013424249,0.33643195,0.00016558406,0.0023535579,0.0012731411,0.05736752,0.071375504],"study_design_scores_gemma":[0.00012610707,0.0006160013,0.38237283,0.0012570531,0.00008021344,0.00048675557,0.54299474,0.00063105574,0.0004440625,0.00019207048,0.07063778,0.00016133972],"about_ca_topic_score_codex":0.7718364,"about_ca_topic_score_gemma":0.7782344,"teacher_disagreement_score":0.2281636,"about_ca_system_score_codex":0.025042323,"about_ca_system_score_gemma":0.063839816,"threshold_uncertainty_score":0.4590146},"labels":[],"label_agreement":null},{"id":"W2523705911","doi":"10.2147/ceor.s113559","title":"Cost-effectiveness of dipeptidyl peptidase-4 inhibitor monotherapy in elderly type 2 diabetes patients in Thailand","year":2016,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; Ottawa Hospital","funders":"","keywords":"Medicine; Dipeptidyl peptidase-4 inhibitor; Cost effectiveness; Type 2 diabetes; Tolerability; Hypoglycemia; Metformin; Type 2 Diabetes Mellitus; Incremental cost-effectiveness ratio; Population; Internal medicine; Diabetes mellitus; Cost-effectiveness analysis; Insulin; Endocrinology; Adverse effect; Environmental health","score_opus":0.0753620826860664,"score_gpt":0.40364102088506476,"score_spread":0.32827893819899834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2523705911","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9040903,0.08634288,0.001209049,0.001317317,0.00010717196,0.0003201615,0.003749308,0.000020753478,0.0028430964],"genre_scores_gemma":[0.9891207,0.009294024,0.0004872774,0.00010979631,0.000021618815,0.00012641081,0.00072796317,0.0000031213187,0.000109165165],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99673945,0.002256616,0.00045975888,0.00014180822,0.00023394007,0.00016842858],"domain_scores_gemma":[0.9957782,0.0025758375,0.0009635947,0.00007713894,0.00029708236,0.00030814932],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0045968406,0.0006568425,0.0015127561,0.001259273,0.00027627457,0.0017701178,0.00043141207,0.00061583245,0.0020508352],"category_scores_gemma":[0.010340175,0.00038344748,0.0060292003,0.0022188397,0.00023771753,0.0009256551,0.0009658704,0.0008594098,0.00006695272],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08526472,0.0016138506,0.3953375,0.03941972,0.083201535,0.0044479026,0.0007454399,0.1705218,0.001650204,0.0031827618,0.0039328462,0.21068177],"study_design_scores_gemma":[0.021359049,0.033584617,0.491334,0.022963444,0.18466063,0.007530902,0.0049870876,0.20919663,0.004015387,0.009879497,0.009866588,0.00062222267],"about_ca_topic_score_codex":0.013139041,"about_ca_topic_score_gemma":0.008745752,"teacher_disagreement_score":0.013139041,"about_ca_system_score_codex":0.0036509756,"about_ca_system_score_gemma":0.0032252958,"threshold_uncertainty_score":0.026489854},"labels":[],"label_agreement":null},{"id":"W2539439489","doi":"10.2147/ceor.s116570","title":"Bringing patient centricity to diabetes medication access in Canada","year":2016,"lang":"en","type":"review","venue":"ClinicoEconomics and Outcomes Research","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Toronto Rehabilitation Institute; Alberta Health; University of Alberta; Alberta Health Services","funders":"AstraZeneca Canada; AstraZeneca","keywords":"Medicine; Diabetes mellitus; Public health; Health care; Gerontology; Rehabilitation; Family medicine; Business; Nursing; Economic growth; Physical therapy","score_opus":0.13138048648490971,"score_gpt":0.4679964293457163,"score_spread":0.33661594286080654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2539439489","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.037143793,0.010593575,0.0023496868,0.87199366,0.0025152096,0.00024706422,0.0013954517,0.00029267973,0.0734688],"genre_scores_gemma":[0.6203213,0.018290386,0.0142638255,0.31992984,0.0019443805,0.00026553424,0.0018868555,0.00036939594,0.022728523],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9865025,0.0021075157,0.00064816396,0.0009384087,0.005426014,0.004377392],"domain_scores_gemma":[0.9303944,0.0051274053,0.0021557894,0.0012266146,0.017098704,0.043997075],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008540773,0.00035154584,0.00076035754,0.0020332858,0.012519958,0.011190666,0.0034654632,0.0037535978,0.013485254],"category_scores_gemma":[0.024629457,0.0006976806,0.0011023927,0.0044341926,0.0048633516,0.003664243,0.008864193,0.0086268205,0.00083843153],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000244297,0.00041461992,0.084702015,0.000940442,0.00030140975,0.002041512,0.007168264,0.0018710737,0.0007472502,0.050970748,0.6221818,0.22841653],"study_design_scores_gemma":[0.00048163746,0.00035931743,0.16335794,0.0028525426,0.00026046624,0.0012209502,0.0135037545,0.0037916033,0.00052979996,0.028543536,0.7846001,0.00049842324],"about_ca_topic_score_codex":0.98208,"about_ca_topic_score_gemma":0.9929253,"teacher_disagreement_score":0.8488518,"about_ca_system_score_codex":0.15114819,"about_ca_system_score_gemma":0.4431075,"threshold_uncertainty_score":0.9845478},"labels":[],"label_agreement":null},{"id":"W2570534554","doi":"10.2147/ceor.s126379","title":"Dalteparin versus vitamin K antagonists for the prevention of recurrent venous thromboembolism in patients with cancer and renal impairment: a Canadian pharmacoeconomic analysis","year":2017,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Pfizer (Canada); McMaster University; Augmentium Pharma Consulting (Canada)","funders":"Pfizer","keywords":"Medicine; Low molecular weight heparin; Confidence interval; Population; Relative risk; Randomized controlled trial; Venous thromboembolism; Internal medicine; Heparin; Pediatrics; Intensive care medicine; Thrombosis","score_opus":0.07103644488420478,"score_gpt":0.44294887340268957,"score_spread":0.37191242851848477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2570534554","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6134534,0.30807358,0.0031546145,0.010811131,0.00044692415,0.0033245923,0.036956165,0.000094544026,0.02368515],"genre_scores_gemma":[0.9466265,0.040139496,0.0023874757,0.0013095007,0.00018039037,0.0003049159,0.0074236253,0.000026884021,0.0016011465],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9954151,0.0014057943,0.0003630577,0.00033585646,0.0019626506,0.0005174134],"domain_scores_gemma":[0.9934708,0.0022131638,0.0011067856,0.00020518256,0.0021924265,0.0008117558],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006381614,0.0013628211,0.003214488,0.0025866292,0.0010179078,0.0018151107,0.0013443257,0.00095150707,0.0035777655],"category_scores_gemma":[0.011059856,0.0005009417,0.008764088,0.0064384774,0.0005244981,0.00035496757,0.00079240283,0.0016308964,0.00012782011],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14886346,0.0011349664,0.36570284,0.029740471,0.16738215,0.00077306805,0.00048001844,0.033282958,0.001557706,0.008345594,0.032733783,0.21000297],"study_design_scores_gemma":[0.04267776,0.0050843954,0.61930263,0.004385072,0.2638301,0.00041350807,0.00055224216,0.032674212,0.0005944431,0.0018739228,0.02825961,0.0003521037],"about_ca_topic_score_codex":0.9112157,"about_ca_topic_score_gemma":0.93924665,"teacher_disagreement_score":0.9112157,"about_ca_system_score_codex":0.03237529,"about_ca_system_score_gemma":0.048367992,"threshold_uncertainty_score":0.2349003},"labels":[],"label_agreement":null},{"id":"W2606890206","doi":"10.2147/ceor.s112254","title":"Cost-effectiveness analysis of abobotulinumtoxinA for the treatment of cervical dystonia in the United Kingdom","year":2017,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Botulinum Toxin and Related Neurological Disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Allergan; Ipsen","keywords":"Cervical dystonia; Medicine; Cost effectiveness; Spasmodic Torticollis; Quality-adjusted life year; Economic evaluation; Quality of life (healthcare); Cost-effectiveness analysis; Formulary; Botulinum toxin; Physical therapy; Dystonia; Surgery; Family medicine; Psychiatry","score_opus":0.3601731427935707,"score_gpt":0.5331505517367018,"score_spread":0.17297740894313107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2606890206","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92397183,0.039459728,0.008108878,0.0041769356,0.0003841802,0.0012444846,0.008609801,0.00012204361,0.013922144],"genre_scores_gemma":[0.99507576,0.0021611375,0.0008799758,0.0002342804,0.000015467815,0.00019599665,0.0008568668,0.000006770715,0.00057374313],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9967931,0.002391961,0.00017989645,0.0001566319,0.00022378039,0.00025468858],"domain_scores_gemma":[0.99464536,0.003967598,0.00063012843,0.00010309506,0.00036448907,0.00028940264],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033036422,0.00081333757,0.0017517261,0.001158451,0.00026576492,0.0015011737,0.00078487233,0.0012980175,0.0047510536],"category_scores_gemma":[0.016445668,0.0007054876,0.0033345846,0.0008544971,0.00041326883,0.0008554335,0.0010535643,0.000879955,0.00021762183],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020156596,0.00047662464,0.027295586,0.004356694,0.0049888045,0.0008690868,0.00013293578,0.89894503,0.0008974292,0.0054560127,0.0048651104,0.03156015],"study_design_scores_gemma":[0.017457046,0.013328509,0.09232817,0.0042362907,0.011029131,0.0020827884,0.00068275427,0.84129685,0.001279604,0.005754087,0.010221443,0.0003033361],"about_ca_topic_score_codex":0.077991724,"about_ca_topic_score_gemma":0.037688065,"teacher_disagreement_score":0.077991724,"about_ca_system_score_codex":0.010839606,"about_ca_system_score_gemma":0.003797546,"threshold_uncertainty_score":0.15507555},"labels":[],"label_agreement":null},{"id":"W2621729744","doi":"10.2147/ceor.s134230","title":"Oncology drugs for orphan indications: how are HTA processes evolving for this specific drug category?","year":2017,"lang":"en","type":"review","venue":"ClinicoEconomics and Outcomes Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Takeda Pharmaceuticals International","keywords":"Orphan drug; Medicine; Oncology; Internal medicine; Pediatric oncology; Health technology; Intensive care medicine; Cancer; Bioinformatics; Health care","score_opus":0.7943854672875345,"score_gpt":0.6411852936115382,"score_spread":0.15320017367599625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2621729744","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015997348,0.43797582,0.04176194,0.40001914,0.0061486876,0.001932754,0.002988023,0.0007402042,0.09243613],"genre_scores_gemma":[0.2274195,0.37378338,0.17284308,0.19920589,0.008678945,0.0026375903,0.0036731462,0.0008828487,0.010875614],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.903086,0.043455016,0.01683082,0.0060018753,0.027428495,0.0031977855],"domain_scores_gemma":[0.56704015,0.28457963,0.044848572,0.01765829,0.078700654,0.007172681],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.12981907,0.0007905376,0.0024476596,0.009846355,0.0022226572,0.019955102,0.003912712,0.0061047995,0.006542928],"category_scores_gemma":[0.30652088,0.0011192193,0.004350915,0.012389548,0.006621785,0.020847002,0.0056800037,0.01145138,0.002228869],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032064616,0.00015276973,0.007858485,0.018493446,0.00048600245,0.00042519084,0.004225621,0.0020119129,0.0008357893,0.13929361,0.08414292,0.7417537],"study_design_scores_gemma":[0.00017491453,0.00044226315,0.013721045,0.050525647,0.000883801,0.0012874489,0.0036565315,0.002274847,0.0020167415,0.062482525,0.8622641,0.00027008253],"about_ca_topic_score_codex":0.024015874,"about_ca_topic_score_gemma":0.022379227,"teacher_disagreement_score":0.12981907,"about_ca_system_score_codex":0.015928388,"about_ca_system_score_gemma":0.05442789,"threshold_uncertainty_score":0.68655705},"labels":[],"label_agreement":null},{"id":"W2742426022","doi":"10.2147/ceor.s139949","title":"The value of corneoscleral rim cultures in keratoplasty: a systematic review and cost-effectiveness analysis","year":2017,"lang":"en","type":"review","venue":"ClinicoEconomics and Outcomes Research","topic":"Corneal surgery and disorders","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St Joseph's Health Care; Western University","funders":"","keywords":"Medicine; Cochrane Library; Endophthalmitis; Meta-analysis; Keratitis; CINAHL; Predictive value; Ophthalmology; Microbiological culture; MEDLINE; Surgery; Internal medicine; Biology; Bacteria","score_opus":0.25716413669056765,"score_gpt":0.5581550544101452,"score_spread":0.3009909177195776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2742426022","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003723437,0.99339783,0.000277875,0.0005500246,0.00014686829,0.000648625,0.0007640991,0.0000157604,0.00047542687],"genre_scores_gemma":[0.11308979,0.8803452,0.002865036,0.00077335833,0.00018431358,0.0019870447,0.0005782415,0.000017890396,0.00015910764],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9734841,0.012957876,0.006841628,0.0011347415,0.0049659945,0.0006156919],"domain_scores_gemma":[0.9128382,0.06840998,0.01151596,0.0007311837,0.0058056563,0.000698995],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.019986538,0.0020624285,0.0140615245,0.014422577,0.0006442152,0.004469322,0.0021355413,0.0025575638,0.0039460855],"category_scores_gemma":[0.09793899,0.0014083808,0.020615598,0.014714912,0.0009609633,0.0032616851,0.0017504509,0.002316976,0.00023197023],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014919951,0.000050930306,0.0021372484,0.9075779,0.04964322,0.00013524674,0.000097738026,0.00069731317,0.000087171335,0.00035005057,0.00092762837,0.036803596],"study_design_scores_gemma":[0.002440521,0.00089416926,0.009121487,0.61625594,0.36177823,0.0006024555,0.00031989627,0.0011960088,0.000246806,0.0007197858,0.0063362634,0.00008850418],"about_ca_topic_score_codex":0.013645882,"about_ca_topic_score_gemma":0.02565442,"teacher_disagreement_score":0.019986538,"about_ca_system_score_codex":0.011768434,"about_ca_system_score_gemma":0.011764724,"threshold_uncertainty_score":0.105700195},"labels":[],"label_agreement":null},{"id":"W2753175606","doi":"10.2147/ceor.s135445","title":"Current recommendations on the estimation of transition probabilities in Markov cohort models for use in health care decision-making: a targeted literature review","year":2017,"lang":"en","type":"review","venue":"ClinicoEconomics and Outcomes Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Takeda Pharmaceuticals International","keywords":"Estimation; MEDLINE; Medicine; Health technology; Health care; Cochrane Library; Markov model; Agency (philosophy); Actuarial science; Operations research; Markov chain; Computer science; Meta-analysis; Machine learning; Political science; Business; Sociology","score_opus":0.691103139678902,"score_gpt":0.6347797981484892,"score_spread":0.05632334153041285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2753175606","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002485988,0.952117,0.013450017,0.025892138,0.0030755585,0.0012754651,0.0010641848,0.00020818527,0.0026689246],"genre_scores_gemma":[0.005820088,0.9340809,0.044884957,0.008583019,0.0012575731,0.0033277988,0.0011756507,0.00010018853,0.0007698498],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9045719,0.05534836,0.023355948,0.0030594252,0.0124698235,0.0011944908],"domain_scores_gemma":[0.5226756,0.40081653,0.023396086,0.005651383,0.04549791,0.0019624992],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.12854397,0.0039970535,0.009062529,0.028511543,0.001655356,0.01085115,0.011525096,0.009668372,0.013103685],"category_scores_gemma":[0.39694166,0.0033752166,0.01816725,0.021424742,0.0033427307,0.012714522,0.0062293014,0.009102624,0.0054456247],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002545888,0.000091548885,0.00062754727,0.47385776,0.0025683884,0.00021235774,0.0011088403,0.0024828569,0.00013007861,0.016383516,0.06234752,0.43993497],"study_design_scores_gemma":[0.00013195528,0.00006063501,0.00044219047,0.8499169,0.0044738073,0.0001453381,0.00031950927,0.0009282015,0.00012137525,0.014509658,0.12886934,0.00008111601],"about_ca_topic_score_codex":0.016764333,"about_ca_topic_score_gemma":0.02508055,"teacher_disagreement_score":0.871456,"about_ca_system_score_codex":0.011062631,"about_ca_system_score_gemma":0.046817586,"threshold_uncertainty_score":0.6798136},"labels":[],"label_agreement":null},{"id":"W2759477597","doi":"10.2147/ceor.s140063","title":"Drug tendering: drug supply and shortage implications for the uptake of biosimilars","year":2017,"lang":"en","type":"review","venue":"ClinicoEconomics and Outcomes Research","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Augmentium Pharma Consulting (Canada)","funders":"Pfizer","keywords":"Biosimilar; Procurement; Medicine; Economic shortage; Incentive; Health care; Business; Risk analysis (engineering); Pharmacology; Marketing; Economic growth","score_opus":0.38833538714832483,"score_gpt":0.5507725914305369,"score_spread":0.1624372042822121,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2759477597","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.051404223,0.013432851,0.005412424,0.8323571,0.0009499733,0.000119049764,0.0007612274,0.00013832039,0.095424786],"genre_scores_gemma":[0.7337121,0.011142465,0.0029837582,0.2294956,0.0034816235,0.00020048422,0.0006425188,0.00016207629,0.018179296],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9857941,0.005084356,0.0007779364,0.0017682506,0.004334196,0.002241161],"domain_scores_gemma":[0.85253954,0.08832315,0.019654889,0.002391666,0.020428685,0.016662145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02029277,0.0003365536,0.0006365354,0.0014849133,0.0024481218,0.008629207,0.0023939358,0.009028071,0.05782453],"category_scores_gemma":[0.092979036,0.00057534006,0.0012163619,0.0018865151,0.0047742277,0.009512637,0.003699204,0.0076555507,0.004396037],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011550166,0.0010082854,0.06669875,0.0014253699,0.00012123907,0.0026400408,0.003377079,0.0039744326,0.0019478223,0.37269822,0.28927118,0.25568265],"study_design_scores_gemma":[0.000985624,0.0012234051,0.08603104,0.004938141,0.00018086127,0.0030143214,0.010207763,0.009756749,0.0016278088,0.36906874,0.512717,0.00024849697],"about_ca_topic_score_codex":0.026196783,"about_ca_topic_score_gemma":0.017185034,"teacher_disagreement_score":0.05782453,"about_ca_system_score_codex":0.011998461,"about_ca_system_score_gemma":0.016027763,"threshold_uncertainty_score":0.19344229},"labels":[],"label_agreement":null},{"id":"W2769848324","doi":"10.2147/ceor.s144695","title":"Do reimbursement recommendation processes used by government drug plans in Canada adhere to good governance principles?","year":2017,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Fraser Institute; Institute of Health Services and Policy Research; Oakville-Trafalgar Memorial Hospital; Canadian Institute for Health Information","funders":"","keywords":"Accountability; Transparency (behavior); Health care; Corporate governance; Public administration; Reimbursement; Agency (philosophy); Government (linguistics); Political science; Public relations; Medicine; Business; Law; Sociology; Finance; Social science","score_opus":0.19176607204055293,"score_gpt":0.42345594978000467,"score_spread":0.23168987773945174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2769848324","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.38756332,0.010755784,0.013515243,0.26426023,0.0010229235,0.0031570273,0.0070726494,0.00062041945,0.3120324],"genre_scores_gemma":[0.94842255,0.0029410669,0.008155673,0.023808308,0.00009917755,0.00036890386,0.0016945682,0.0001233181,0.014386566],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9125721,0.013642171,0.0051641613,0.005238224,0.044596255,0.018787142],"domain_scores_gemma":[0.7987119,0.03785969,0.029779706,0.012162226,0.10512095,0.01636555],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.044421636,0.00040202469,0.0009841317,0.0037963344,0.01567402,0.018677449,0.00414193,0.0033695865,0.006478342],"category_scores_gemma":[0.17403041,0.0009232509,0.0012753882,0.0143853305,0.007290255,0.0060860394,0.00379374,0.0050851246,0.00087926013],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00033077606,0.000499679,0.34975377,0.0010266582,0.00039934652,0.0006856827,0.049986456,0.005051182,0.00076716155,0.21007326,0.14477754,0.2366484],"study_design_scores_gemma":[0.00025957724,0.00014578528,0.6263693,0.0013833205,0.00022165287,0.00023505013,0.027620532,0.00620614,0.0009956764,0.019699363,0.31633586,0.0005278054],"about_ca_topic_score_codex":0.9935243,"about_ca_topic_score_gemma":0.9949995,"teacher_disagreement_score":0.76253456,"about_ca_system_score_codex":0.23746546,"about_ca_system_score_gemma":0.4296468,"threshold_uncertainty_score":0.88443196},"labels":[],"label_agreement":null},{"id":"W2789439243","doi":"10.2147/ceor.s154323","title":"Clinical and economic burden of idiopathic pulmonary fibrosis in Quebec, Canada","year":2018,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université Laval; McMaster University; Hôpital du Saint-Sacrement; Programs for Assessment of Technology in Health Research Institute; St. Joseph’s Healthcare Hamilton; University of Calgary; Impact","funders":"","keywords":"Medicine; Idiopathic pulmonary fibrosis; Pulmonary fibrosis; Intensive care medicine; Fibrosis; Pathology; Internal medicine; Lung","score_opus":0.04095241265247752,"score_gpt":0.3918457891416383,"score_spread":0.3508933764891608,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2789439243","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.83223796,0.019712256,0.0009959557,0.011289564,0.00016635591,0.0002678576,0.111723535,0.00011613016,0.023490386],"genre_scores_gemma":[0.975251,0.0051159738,0.00097436254,0.0006954247,0.000041102277,0.00006572235,0.015236994,0.000014513819,0.0026047805],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987025,0.0001638399,0.000080081176,0.000113383205,0.00056419446,0.0003758722],"domain_scores_gemma":[0.99631065,0.00021391723,0.0007525931,0.000055370536,0.0018583759,0.00080903544],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000789498,0.0004480311,0.0003528629,0.0024486925,0.0019225103,0.0017845588,0.0010577746,0.00041262285,0.003523042],"category_scores_gemma":[0.0029434706,0.00020195857,0.0006130505,0.005670994,0.00049314223,0.00043709288,0.0007876468,0.0006725365,0.00023044783],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010607082,0.00004750784,0.95576215,0.00020811713,0.00030429283,0.00029098,0.00023243506,0.0021207165,0.00014209485,0.0010331367,0.020014869,0.019737625],"study_design_scores_gemma":[0.000027378634,0.000024235589,0.9883809,0.00026743146,0.00008511781,0.0001709178,0.0006253995,0.0028178564,0.000053565356,0.00014715065,0.0073757037,0.00002446493],"about_ca_topic_score_codex":0.9974336,"about_ca_topic_score_gemma":0.9979036,"teacher_disagreement_score":0.9386662,"about_ca_system_score_codex":0.061333783,"about_ca_system_score_gemma":0.049381085,"threshold_uncertainty_score":0.44500983},"labels":[],"label_agreement":null},{"id":"W2790036407","doi":"10.2147/ceor.s150900","title":"Oral versus intravenous iron therapy in patients with inflammatory bowel disease and iron deficiency with and without anemia in Germany – a real-world evidence analysis","year":2018,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Vifor Pharma","keywords":"Medicine; Intravenous iron; Iron deficiency; Iron-deficiency anemia; Anemia; Propensity score matching; Inflammatory bowel disease; Internal medicine; Pediatrics; Disease","score_opus":0.05395523311786152,"score_gpt":0.3973452044950837,"score_spread":0.34338997137722216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2790036407","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.22275029,0.7680451,0.00070828904,0.0016922907,0.00027358954,0.0006243075,0.0038030942,0.000012554082,0.0020904613],"genre_scores_gemma":[0.8988487,0.09759847,0.0010504773,0.0005619151,0.00020270473,0.0003869575,0.0011605449,0.0000053270733,0.00018484113],"study_design_codex":"meta_analysis","study_design_gemma":"observational","domain_scores_codex":[0.9941829,0.0033210309,0.001131848,0.00041458543,0.00073619286,0.0002135017],"domain_scores_gemma":[0.99096394,0.004511554,0.0037932335,0.00014715553,0.0003513794,0.00023277513],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005931671,0.00046901495,0.0023093456,0.0025345616,0.00019804781,0.0015084106,0.000557013,0.0008497593,0.0029554486],"category_scores_gemma":[0.0142298285,0.00030748322,0.006635946,0.0022310482,0.0003500818,0.00081676454,0.000819545,0.0008044898,0.00013169668],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07532157,0.00076213595,0.14100574,0.22504073,0.2743274,0.0005121936,0.0002828669,0.0022362377,0.0004588562,0.002087492,0.004664886,0.27329984],"study_design_scores_gemma":[0.03103621,0.012452213,0.26960912,0.0849024,0.5721462,0.0013734093,0.0009536841,0.0044777845,0.00064698455,0.0022984191,0.019942774,0.00016084629],"about_ca_topic_score_codex":0.002701589,"about_ca_topic_score_gemma":0.0054723592,"teacher_disagreement_score":0.005931671,"about_ca_system_score_codex":0.0020726349,"about_ca_system_score_gemma":0.0015373409,"threshold_uncertainty_score":0.031370044},"labels":[],"label_agreement":null},{"id":"W2794182884","doi":"10.2147/ceor.s144208","title":"Modeling the economic outcomes of immuno-oncology drugs: alternative model frameworks to capture clinical outcomes","year":2018,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Bristol-Myers Squibb (Canada); Augmentium Pharma Consulting (Canada)","funders":"Bristol-Myers Squibb","keywords":"Medicine; Clinical trial; Quality-adjusted life year; Markov model; Time horizon; Quality of life (healthcare); Disease; Economic model; Matching (statistics); Intensive care medicine; Oncology; Markov chain; Internal medicine; Machine learning; Computer science; Cost effectiveness; Risk analysis (engineering); Pathology; Mathematics","score_opus":0.5255296714953919,"score_gpt":0.6089148835745423,"score_spread":0.0833852120791504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2794182884","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.28133303,0.0025262912,0.6903221,0.009024901,0.00016951734,0.0004813159,0.0020017454,0.00014488542,0.013996142],"genre_scores_gemma":[0.9401615,0.001304122,0.053021565,0.0005525232,0.00011035409,0.000691772,0.00064888207,0.000033360855,0.003475931],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9974407,0.0019521733,0.00007435954,0.00017228836,0.00017133736,0.00018916962],"domain_scores_gemma":[0.9839298,0.013936942,0.0011369897,0.00031860778,0.00045064618,0.00022690426],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008338432,0.0010544563,0.0010641853,0.0013284329,0.00040933405,0.0020461397,0.0019079589,0.0018359692,0.003801116],"category_scores_gemma":[0.02076501,0.0005725452,0.0020058851,0.0015125904,0.0010103441,0.0023669954,0.0012179666,0.002500507,0.00028888063],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000057870522,0.000047083227,0.0018177686,0.00003903229,0.00005269995,0.000036308193,0.00005319505,0.9644882,0.000041664887,0.029954653,0.00029937187,0.0031122642],"study_design_scores_gemma":[0.000049772178,0.000059068956,0.00070501777,0.000036628095,0.000034766337,0.000020710431,0.000033786822,0.9540802,0.000033389944,0.044293176,0.0006392664,0.000014210173],"about_ca_topic_score_codex":0.014778109,"about_ca_topic_score_gemma":0.011845428,"teacher_disagreement_score":0.014778109,"about_ca_system_score_codex":0.0035214166,"about_ca_system_score_gemma":0.002004637,"threshold_uncertainty_score":0.044098377},"labels":[],"label_agreement":null},{"id":"W2795793258","doi":"10.2147/ceor.s155038","title":"Clinical outcomes and health care utilization pre- and post-laparoscopic radiofrequency ablation of symptomatic fibroids and laparoscopic myomectomy: a randomized trial of uterine-sparing techniques (TRUST) in Canada","year":2018,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Uterine Myomas and Treatments","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Impact; Programs for Assessment of Technology in Health Research Institute; University of Saskatchewan; Regina General Hospital","funders":"","keywords":"Medicine; Randomized controlled trial; Uterine fibroids; Radiofrequency ablation; Uterine myomectomy; Ablation; Laparoscopy; Clinical trial; General surgery; Obstetrics; Surgery; Myoma; Uterus; Internal medicine","score_opus":0.07032429785884224,"score_gpt":0.45542597000724355,"score_spread":0.3851016721484013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2795793258","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976859,0.00070864003,0.00005855669,0.00014537384,0.000055442153,0.000713342,0.00023914254,0.0000054493016,0.00038824405],"genre_scores_gemma":[0.9975223,0.00054403994,0.00022542065,0.00016044894,0.00007575154,0.00044806785,0.0003677483,0.000001888858,0.000654424],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9982023,0.0007636384,0.00010279319,0.00025528908,0.00025766582,0.00041826998],"domain_scores_gemma":[0.99773645,0.0003987504,0.00051092985,0.00008317609,0.0003170878,0.0009535814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018529024,0.00081391865,0.0015500262,0.0003250061,0.00095201936,0.0008759855,0.0008035926,0.0013159617,0.0037224705],"category_scores_gemma":[0.0033721,0.00069567247,0.0015512013,0.00059481745,0.0014997635,0.00043381797,0.00044148497,0.0013594255,0.00018303328],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.94052905,0.011703843,0.032289896,0.00042101438,0.001303459,0.000055972687,0.00015022271,0.00040198272,0.0010615193,0.00015867467,0.00065661094,0.011267606],"study_design_scores_gemma":[0.6581025,0.16651642,0.1679453,0.00014619742,0.0024986528,0.00008797998,0.00038449955,0.00244405,0.00069455896,0.00016671274,0.00094267784,0.000070515925],"about_ca_topic_score_codex":0.28499562,"about_ca_topic_score_gemma":0.36995643,"teacher_disagreement_score":0.7150044,"about_ca_system_score_codex":0.0068105697,"about_ca_system_score_gemma":0.013080594,"threshold_uncertainty_score":0.5666735},"labels":[],"label_agreement":null},{"id":"W2896465630","doi":"10.2147/ceor.s167500","title":"Economic analysis of pharmacist-administered influenza vaccines in Ontario, Canada","year":2018,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Neighbourhood Pharmacy Association of Canada; University of Waterloo; McMaster University; Impact; Programs for Assessment of Technology in Health Research Institute","funders":"University of Waterloo","keywords":"Vaccination; Medicine; Influenza vaccine; Productivity; Pharmacist; Health care; Influenza season; Immunization; Indirect costs; Population; Environmental health; Family medicine; Pharmacy; Virology; Immunology; Business; Economic growth","score_opus":0.2505315414352499,"score_gpt":0.5190118989641723,"score_spread":0.2684803575289224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2896465630","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9065055,0.018471457,0.0051056375,0.005058191,0.00016112375,0.0021136089,0.016090304,0.000092167684,0.046401974],"genre_scores_gemma":[0.99127907,0.0025593617,0.0013532421,0.00020059514,0.000018906245,0.00019532035,0.0015686307,0.000010659192,0.0028142459],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9964132,0.0014176498,0.00013817317,0.00017093541,0.0010864296,0.00077380467],"domain_scores_gemma":[0.99559385,0.0018706204,0.0006276742,0.000090562986,0.0013983316,0.00041889484],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004002007,0.00078110845,0.0009279931,0.0011669063,0.0010088874,0.0018779455,0.0011382804,0.00064465654,0.0028106715],"category_scores_gemma":[0.013057161,0.0004887855,0.0017228067,0.002062935,0.00055978936,0.0006696823,0.0007437422,0.0007489314,0.000089519395],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0063114543,0.00067353353,0.18277344,0.004156172,0.0041385605,0.0011460885,0.0005323847,0.7202119,0.0017051282,0.013833289,0.013162959,0.05135506],"study_design_scores_gemma":[0.002900075,0.0022309264,0.36994568,0.0013020054,0.003992089,0.0003941751,0.0013561869,0.5843476,0.0013690963,0.0039287023,0.027979992,0.00025352574],"about_ca_topic_score_codex":0.9812934,"about_ca_topic_score_gemma":0.9743954,"teacher_disagreement_score":0.12024601,"about_ca_system_score_codex":0.12024601,"about_ca_system_score_gemma":0.07629414,"threshold_uncertainty_score":0.87244993},"labels":[],"label_agreement":null},{"id":"W2903168985","doi":"10.2147/ceor.s178825","title":"A methodological review of national and transnational pharmaceutical budget impact analysis guidelines for new drug submissions","year":2018,"lang":"en","type":"review","venue":"ClinicoEconomics and Outcomes Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; St. Joseph’s Healthcare Hamilton; Impact; Programs for Assessment of Technology in Health Research Institute","funders":"","keywords":"EconLit; Formulary; CINAHL; Medicine; Grey literature; MEDLINE; Health care; Population; Family medicine; Political science; Environmental health; Nursing; Psychological intervention","score_opus":0.9495857588377236,"score_gpt":0.7667037290534521,"score_spread":0.18288202978427148,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2903168985","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003641131,0.9047138,0.022451371,0.011277037,0.0023555357,0.036252875,0.010262489,0.00020645054,0.008839216],"genre_scores_gemma":[0.052785307,0.72343194,0.09128949,0.007075492,0.00071713695,0.1160188,0.0072632697,0.00029237443,0.0011261578],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.41952404,0.30572185,0.19552939,0.0104623865,0.0657332,0.0030290927],"domain_scores_gemma":[0.32247066,0.43629804,0.097937085,0.023729991,0.117603384,0.001960828],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.41514197,0.0033248966,0.012378542,0.060663648,0.0031410095,0.014929844,0.007923707,0.0042659957,0.008497721],"category_scores_gemma":[0.69284886,0.003942625,0.019269345,0.06804896,0.0037082904,0.0106581,0.010250396,0.004514252,0.00136866],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039177013,0.0000743767,0.0022545867,0.7921152,0.008271711,0.00014079628,0.0027585272,0.0008696178,0.000121269724,0.006262842,0.016362846,0.17037651],"study_design_scores_gemma":[0.00030999127,0.00012707616,0.0026361863,0.90610325,0.013291946,0.00011937769,0.0013993392,0.0003679565,0.00026801412,0.0023400418,0.07293188,0.0001048125],"about_ca_topic_score_codex":0.019303596,"about_ca_topic_score_gemma":0.032949183,"teacher_disagreement_score":0.58485806,"about_ca_system_score_codex":0.028475145,"about_ca_system_score_gemma":0.09797028,"threshold_uncertainty_score":0.7212341},"labels":[{"model":"gemma","categories":["metaresearch"],"domain":"methods","study_design":"not_applicable","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":["metaresearch"],"domain":"methods","study_design":"systematic_review","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"split"},{"id":"W2942923076","doi":"10.2147/ceor.s195597","title":"<p>Electronic referral systems in health care: a scoping review</p>","year":2019,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Healthcare Systems and Technology","field":"Business, Management and Accounting","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; Programs for Assessment of Technology in Health Research Institute; Impact; McMaster University","funders":"","keywords":"Referral; Workflow; Medicine; Psychological intervention; Economic evaluation; Cost effectiveness; Healthcare system; Health care; Quality (philosophy); Cost–benefit analysis; Electronic database; Family medicine; Operations management; Medical emergency; Nursing; Computer science; Risk analysis (engineering); Database; Engineering; Pathology","score_opus":0.08609600033652381,"score_gpt":0.427272705291,"score_spread":0.34117670495447616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2942923076","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00046222695,0.9953382,0.0002473898,0.0015888741,0.00043115814,0.000343304,0.00021351204,0.000012980744,0.0013624452],"genre_scores_gemma":[0.005323225,0.99109906,0.0010528703,0.0009292749,0.00032743072,0.00067750213,0.00025543265,0.000010690135,0.0003245055],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.98102796,0.006557188,0.006156658,0.0012974185,0.0043142033,0.0006465022],"domain_scores_gemma":[0.84128404,0.12668131,0.016407978,0.0018902613,0.012721545,0.001014876],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02450402,0.0014245462,0.0037681854,0.022773838,0.0014318909,0.006570773,0.002167301,0.0046964637,0.011523978],"category_scores_gemma":[0.11026452,0.0012201971,0.005159552,0.031220539,0.0021332765,0.0053830505,0.0029426883,0.0026331937,0.0015254812],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014264096,0.00005679376,0.000857147,0.77371716,0.0011805058,0.00011886712,0.00054504804,0.00023976876,0.00019243595,0.0019244605,0.010655227,0.21036996],"study_design_scores_gemma":[0.000040594186,0.000074017415,0.0014692675,0.96724004,0.0026337854,0.00012554841,0.00026971,0.0000911721,0.000112945665,0.0006162559,0.027309686,0.000016969527],"about_ca_topic_score_codex":0.011895939,"about_ca_topic_score_gemma":0.015632022,"teacher_disagreement_score":0.02450402,"about_ca_system_score_codex":0.007862778,"about_ca_system_score_gemma":0.026829747,"threshold_uncertainty_score":0.12959123},"labels":[],"label_agreement":null},{"id":"W2965199654","doi":"10.2147/ceor.s208107","title":"<p>A Canadian cost-effectiveness analysis of SAPIEN 3 transcatheter aortic valve implantation compared with surgery, in intermediate and high-risk severe aortic stenosis patients</p>","year":2019,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Cardiac Valve Diseases and Treatments","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; St. Joseph’s Healthcare Hamilton; Impact","funders":"","keywords":"Medicine; Stenosis; Aortic valve replacement; Aortic valve; Cardiology; Internal medicine; Surgery; Emergency medicine","score_opus":0.03145730732039322,"score_gpt":0.3730813773028239,"score_spread":0.3416240699824307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2965199654","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9248762,0.016420145,0.003448725,0.0042082444,0.00021590234,0.0012708602,0.029695172,0.00012983645,0.019735012],"genre_scores_gemma":[0.9890798,0.0022152103,0.0023553618,0.0003546152,0.000026978654,0.0001774903,0.0044349604,0.00002185988,0.0013337411],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9984144,0.00066073047,0.00006460321,0.00014779772,0.00034445978,0.00036798362],"domain_scores_gemma":[0.99563086,0.0022433002,0.00051174656,0.00010646826,0.00089501456,0.0006125844],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032414817,0.0012950667,0.0016423232,0.0016164791,0.0008986926,0.0017137784,0.0017285922,0.0009514435,0.004517776],"category_scores_gemma":[0.011201567,0.0006092925,0.0040889666,0.00254964,0.00067914254,0.00058222155,0.0007944151,0.0014657367,0.00013427333],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.034949783,0.0012969191,0.077428766,0.0062080687,0.012324985,0.0007859171,0.00029223552,0.7707004,0.0015156397,0.016498119,0.027594076,0.050405174],"study_design_scores_gemma":[0.015198618,0.0046463767,0.15924309,0.0017989672,0.013409183,0.00065240235,0.0007285279,0.78569907,0.001031659,0.0049387175,0.012069866,0.0005835515],"about_ca_topic_score_codex":0.95093644,"about_ca_topic_score_gemma":0.9348948,"teacher_disagreement_score":0.05788001,"about_ca_system_score_codex":0.05788001,"about_ca_system_score_gemma":0.051737424,"threshold_uncertainty_score":0.41995084},"labels":[],"label_agreement":null},{"id":"W2992911505","doi":"10.2147/ceor.s224277","title":"<p>Canadian Medication Cost Savings Associated with Combinatorial Pharmacogenomic Guidance for Psychiatric Medications</p>","year":2019,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"Assurex Health","keywords":"Formulary; Medicine; Medical prescription; Pharmacogenomics; Pharmacy; Antipsychotic; Psychiatry; Test (biology); Family medicine; Schizophrenia (object-oriented programming); Pharmacology","score_opus":0.112147836875957,"score_gpt":0.483614907670712,"score_spread":0.37146707079475505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2992911505","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93556446,0.0047089206,0.0032700975,0.0050081112,0.00007438822,0.0005479551,0.028224733,0.00020662587,0.022394666],"genre_scores_gemma":[0.9873569,0.0011830463,0.0038896168,0.0005455352,0.000038273043,0.00008449079,0.0054223244,0.000020598867,0.0014592207],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99772745,0.0003321513,0.00010326659,0.00019906845,0.0013783836,0.00025972805],"domain_scores_gemma":[0.9965848,0.0005227993,0.0012695817,0.000118802156,0.0011406427,0.00036339802],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011525452,0.00062685815,0.00028474617,0.0017643733,0.0007592023,0.0012575693,0.0010216049,0.00050599553,0.0032819659],"category_scores_gemma":[0.008258001,0.00032752746,0.0013143296,0.0023480153,0.00037999955,0.00043094062,0.00082302367,0.0006699545,0.00021781196],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010086527,0.00015441683,0.8670365,0.00050984364,0.0013788247,0.00019337554,0.00016836094,0.020581296,0.00035895867,0.0020086304,0.016480604,0.090120494],"study_design_scores_gemma":[0.00021761177,0.00035554668,0.9527123,0.0002504916,0.0008111417,0.0003278637,0.00025279255,0.033703037,0.0007146036,0.0005123032,0.0100757005,0.00006666802],"about_ca_topic_score_codex":0.9486081,"about_ca_topic_score_gemma":0.95123786,"teacher_disagreement_score":0.96499085,"about_ca_system_score_codex":0.035009146,"about_ca_system_score_gemma":0.032410502,"threshold_uncertainty_score":0.25401032},"labels":[],"label_agreement":null},{"id":"W2995955619","doi":"10.2147/ceor.s156558","title":"<p>North American cost analysis of brand name versus generic drugs for the treatment of glaucoma</p>","year":2019,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Glaucoma and retinal disorders","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Waterloo; Western University","funders":"","keywords":"Medicine; Glaucoma; Formulary; Medical prescription; Pharmacy; Brand names; Generic drug; Family medicine; Optometry; Drug; Pharmacology; Ophthalmology; Advertising; Business","score_opus":0.053594725341810145,"score_gpt":0.39482335125487306,"score_spread":0.3412286259130629,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995955619","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88888675,0.025307205,0.0059389966,0.005209207,0.00023908698,0.0012540751,0.0230315,0.0001123193,0.050020814],"genre_scores_gemma":[0.9821675,0.003118102,0.003423806,0.00075995625,0.00008480525,0.0005016238,0.005586593,0.00003138022,0.004326285],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9973137,0.0015115481,0.000094757146,0.00016546284,0.00065477873,0.00025986534],"domain_scores_gemma":[0.997336,0.0012919575,0.00036904716,0.00007868566,0.0007483814,0.00017584466],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003264928,0.0005217492,0.00069929886,0.0025512632,0.0005533477,0.0013687974,0.00080683746,0.00045617952,0.004105445],"category_scores_gemma":[0.006703835,0.00037003172,0.002514662,0.004645028,0.0002658858,0.0006694695,0.00051767717,0.00066494365,0.00019864504],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02734531,0.0017468869,0.19299878,0.0044032163,0.010430356,0.0009125743,0.00049284886,0.40412742,0.0018332883,0.040189262,0.097207986,0.21831207],"study_design_scores_gemma":[0.003518653,0.0033361868,0.46305498,0.0011410606,0.008682769,0.0010554561,0.0016537159,0.44698444,0.001518258,0.008063657,0.060679417,0.00031143957],"about_ca_topic_score_codex":0.2796809,"about_ca_topic_score_gemma":0.25565267,"teacher_disagreement_score":0.2796809,"about_ca_system_score_codex":0.01569942,"about_ca_system_score_gemma":0.008645004,"threshold_uncertainty_score":0.556106},"labels":[],"label_agreement":null},{"id":"W3010771737","doi":"10.2147/ceor.s234298","title":"<p>Stated Preferences for Attributes of a <em>CYP2C19</em> Pharmacogenetic Test Among the General Population Presented with a Hypothetical Acute Coronary Syndrome Scenario</p>","year":2020,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Economic and Environmental Valuation","field":"Economics, Econometrics and Finance","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Eli Lilly (Canada); University of Ottawa; University of Toronto","funders":"","keywords":"Medicine; Acute coronary syndrome; Turnaround time; Test (biology); Point of care; CYP2C19; Pharmacogenetics; Willingness to pay; Population; Preference; Family medicine; Emergency medicine; Internal medicine; Statistics; Computer science; Nursing; Environmental health","score_opus":0.15448870244248053,"score_gpt":0.3364111831194406,"score_spread":0.1819224806769601,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3010771737","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99538887,0.0000145888735,0.0007450202,0.000286419,0.000007599745,0.00043236185,0.0007235908,0.000008262665,0.0023932622],"genre_scores_gemma":[0.995874,0.00002562794,0.0017196125,0.00020920955,0.0000054749503,0.00060524384,0.0003424696,0.0000023452626,0.001215969],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.995836,0.0025304123,0.0002616307,0.00034031738,0.0005842836,0.0004472656],"domain_scores_gemma":[0.9814974,0.012295481,0.0026502714,0.0010423944,0.0014229509,0.001091465],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0073280456,0.00033661697,0.0003366306,0.00027788096,0.0006554505,0.0012019073,0.00038390854,0.0009285379,0.0055964226],"category_scores_gemma":[0.020857869,0.0002115898,0.0008099238,0.00031344246,0.0012112446,0.00048109726,0.00049579534,0.0008217929,0.0005791752],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0066568498,0.004697031,0.92253864,0.00029038833,0.00036994455,0.0005010539,0.007203869,0.008504709,0.0031921857,0.0017489041,0.0052694604,0.03902688],"study_design_scores_gemma":[0.0010104978,0.0060694544,0.9462331,0.00013815325,0.00019177332,0.00022699813,0.008443654,0.025734602,0.0024976274,0.0018174466,0.0074718175,0.0001648232],"about_ca_topic_score_codex":0.100206785,"about_ca_topic_score_gemma":0.114667624,"teacher_disagreement_score":0.100206785,"about_ca_system_score_codex":0.0047455668,"about_ca_system_score_gemma":0.0029847822,"threshold_uncertainty_score":0.19924706},"labels":[],"label_agreement":null},{"id":"W3023368852","doi":"10.2147/ceor.s238725","title":"<p>Economic Evaluation of Single versus Combination Immuno-Oncology Therapies: Application of a Novel Modelling Approach in Metastatic Melanoma</p>","year":2020,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Augmentium Pharma Consulting (Canada)","funders":"Bristol-Myers Squibb","keywords":"Medicine; Ipilimumab; Oncology; Progression-free survival; Regimen; Internal medicine; Clinical trial; Nivolumab; Metastatic melanoma; Cancer; Overall survival; Immunotherapy","score_opus":0.22576595778938763,"score_gpt":0.429442170650173,"score_spread":0.20367621286078536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3023368852","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.41864505,0.002461057,0.5167069,0.005647143,0.00021543427,0.0010208519,0.0031576573,0.00034618864,0.051799715],"genre_scores_gemma":[0.9336398,0.0007624852,0.05812492,0.00020186184,0.00005503008,0.00068636856,0.00045584506,0.000057506815,0.0060162693],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9990483,0.0007128506,0.00002387418,0.00008028327,0.000076925,0.000057851135],"domain_scores_gemma":[0.99467695,0.0046753446,0.0002793223,0.00010209836,0.00017087108,0.00009542888],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004257406,0.0007481987,0.0010047011,0.0007815071,0.00028967907,0.0015126899,0.0010717936,0.0017702846,0.0057679336],"category_scores_gemma":[0.007189566,0.0005049702,0.0016935929,0.0008248283,0.0005270673,0.0011602665,0.00087309437,0.0012871621,0.00023793751],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009142127,0.000051334748,0.0006390736,0.00008816726,0.00004700698,0.00007424102,0.000019460813,0.98604715,0.00014413192,0.00762808,0.0005575293,0.004612428],"study_design_scores_gemma":[0.000026251026,0.00006198688,0.00022060818,0.000017080176,0.000021203658,0.000013581396,0.000012775636,0.99565923,0.000068560636,0.0034254421,0.00046742143,0.000005807924],"about_ca_topic_score_codex":0.012545517,"about_ca_topic_score_gemma":0.009030349,"teacher_disagreement_score":0.012545517,"about_ca_system_score_codex":0.0028650572,"about_ca_system_score_gemma":0.0022891064,"threshold_uncertainty_score":0.02494502},"labels":[],"label_agreement":null},{"id":"W3046450200","doi":"10.2147/ceor.s252244","title":"<p>Socioeconomic Inequality in Self-Medication in Iran: Cross-Sectional Analyses at the National and Subnational Levels</p>","year":2020,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Antibiotic Use and Resistance","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"Kermanshah University of Medical Sciences","keywords":"Socioeconomic status; Inequality; Cross-sectional study; Confidence interval; Geography; Proxy (statistics); Medicine; Socioeconomics; Demography; Environmental health; Population; Economics; Mathematics; Statistics; Sociology","score_opus":0.20165184383066015,"score_gpt":0.4650078080743688,"score_spread":0.26335596424370866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3046450200","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979819,0.00024622295,0.00012706712,0.00010584909,0.000010046897,0.000023287223,0.0009720227,0.0000029554897,0.0005307687],"genre_scores_gemma":[0.998538,0.00014727429,0.0002057278,0.0000488726,0.000011381273,0.000030624848,0.00087248144,0.000001590278,0.0001440483],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995147,0.00012090021,0.00006646637,0.00008822669,0.000115437964,0.00009421205],"domain_scores_gemma":[0.99888235,0.00015613833,0.000510503,0.000103839186,0.00021343511,0.00013383484],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013378654,0.00023972458,0.00026528467,0.0009748506,0.0004926672,0.000537687,0.0004309474,0.00031561079,0.0016732106],"category_scores_gemma":[0.0020382593,0.00031476817,0.000953708,0.0016589803,0.0002898871,0.0005319113,0.0006180439,0.0007132245,0.00021359001],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014978524,0.000022259801,0.9987204,0.000009358467,0.000050309165,0.000013700362,0.00010658721,0.000019817393,0.000016824448,0.00002392598,0.0001303495,0.00087151513],"study_design_scores_gemma":[0.0000014210178,0.000024218789,0.99931645,0.000007717314,0.000026648928,0.00003009912,0.00028800694,0.00013804261,0.000016458547,0.000015261174,0.00013372379,0.0000018025539],"about_ca_topic_score_codex":0.029373074,"about_ca_topic_score_gemma":0.032049168,"teacher_disagreement_score":0.029373074,"about_ca_system_score_codex":0.0005970966,"about_ca_system_score_gemma":0.00073168747,"threshold_uncertainty_score":0.058404207},"labels":[],"label_agreement":null},{"id":"W3081149819","doi":"10.2147/ceor.s264589","title":"<p>Can Standard Health Technology Assessment Approaches Help Guide the Price of Orphan Drugs in Canada? A Review of Submissions to the Canadian Agency for Drugs and Technologies in Health Common Drug Review</p>","year":2020,"lang":"en","type":"review","venue":"ClinicoEconomics and Outcomes Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Orphan drug; Medicine; Reimbursement; Health technology; Per capita; Agency (philosophy); Excellence; Family medicine; Health care; Environmental health; Population; Economic growth","score_opus":0.45923800031079876,"score_gpt":0.5528400443968733,"score_spread":0.09360204408607453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3081149819","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0054527605,0.72055227,0.0038456758,0.15948483,0.009504977,0.0024494964,0.011559518,0.00046676258,0.08668376],"genre_scores_gemma":[0.07419782,0.7867256,0.027356457,0.06421597,0.00377808,0.0010975694,0.0077946717,0.00031960558,0.034514196],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9342111,0.006570027,0.007386489,0.0017715963,0.04712109,0.0029396939],"domain_scores_gemma":[0.60019183,0.035259165,0.016548948,0.0030464064,0.33883217,0.006121474],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.049544945,0.0010513834,0.0018259292,0.029186275,0.0041256137,0.0097200405,0.0042836033,0.003293864,0.0038308438],"category_scores_gemma":[0.12719555,0.0009479242,0.002332913,0.029762875,0.004442869,0.0032759784,0.0014102793,0.0031667436,0.0012834625],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001306679,0.00006018568,0.0052971886,0.0207677,0.00029408638,0.0004725139,0.0010448255,0.000705949,0.0008561001,0.011382683,0.5920538,0.3669343],"study_design_scores_gemma":[0.000053662043,0.0000602163,0.023094114,0.017027127,0.0003759071,0.00023185395,0.00081295107,0.00061080576,0.000641219,0.0011239093,0.95582336,0.00014475935],"about_ca_topic_score_codex":0.91260046,"about_ca_topic_score_gemma":0.9562071,"teacher_disagreement_score":0.9112024,"about_ca_system_score_codex":0.08879761,"about_ca_system_score_gemma":0.31726682,"threshold_uncertainty_score":0.6442747},"labels":[],"label_agreement":null},{"id":"W3127435253","doi":"10.2147/ceor.s282253","title":"Short and Mid-Term Economic Impact of Pulmonary Artery Catheter Use in Adult Cardiac Surgery: A Hospital and Integrated Health System Perspective","year":2021,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Hemodynamic Monitoring and Therapy","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Edwards Lifesciences","keywords":"Medicine; Pulmonary artery catheter; Cardiac surgery; Catheter; Emergency medicine; Intensive care medicine; Surgery; Internal medicine; Cardiac output; Hemodynamics","score_opus":0.05843146478753089,"score_gpt":0.4216618694035618,"score_spread":0.36323040461603096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3127435253","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9484193,0.0058515226,0.0072811292,0.0060231998,0.00012884397,0.00023325912,0.008834844,0.000042966774,0.023184998],"genre_scores_gemma":[0.9970868,0.00072503526,0.00076278794,0.00018561585,0.000020871508,0.000036061083,0.00066663336,0.000007528928,0.0005086073],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.99693066,0.0019359408,0.00013407134,0.00017796902,0.0003417901,0.00047956756],"domain_scores_gemma":[0.9944923,0.0032937105,0.0008866944,0.0001187316,0.000731193,0.00047740855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036052708,0.00087554863,0.0006331623,0.0016974952,0.00045764365,0.003137555,0.00095907773,0.0014638528,0.004266417],"category_scores_gemma":[0.010343551,0.00055791624,0.002151548,0.0020512189,0.0006542363,0.0021903473,0.0016164706,0.0015195538,0.00023633536],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009232241,0.00039040856,0.075598046,0.0004194012,0.0017091566,0.0009666575,0.00015247658,0.89086616,0.0006397539,0.012873197,0.0022239655,0.013237583],"study_design_scores_gemma":[0.00031992033,0.0027744498,0.15129308,0.000977898,0.0026852563,0.0011165171,0.002290264,0.81034124,0.0014493451,0.018021667,0.008510983,0.00021936855],"about_ca_topic_score_codex":0.03086235,"about_ca_topic_score_gemma":0.026257733,"teacher_disagreement_score":0.03086235,"about_ca_system_score_codex":0.008051908,"about_ca_system_score_gemma":0.0035288536,"threshold_uncertainty_score":0.061365426},"labels":[],"label_agreement":null},{"id":"W3159645717","doi":"10.2147/ceor.s304600","title":"Cost-Effectiveness of Repository Corticotropin Injection versus Standard of Care for the Treatment of Active Rheumatoid Arthritis","year":2021,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Mallinckrodt Pharmaceuticals","keywords":"Medicine; Rheumatoid arthritis; Quality of life (healthcare); Quality-adjusted life year; Cost effectiveness; Internal medicine; Physical therapy; Pediatrics","score_opus":0.08182627797173322,"score_gpt":0.43082203205475506,"score_spread":0.34899575408302186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3159645717","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97671026,0.00563339,0.011305885,0.00074701034,0.00007865994,0.00090129947,0.0012971802,0.00009334625,0.0032328898],"genre_scores_gemma":[0.9964114,0.0005183387,0.0022127957,0.00007437048,0.000009851356,0.0002241829,0.00033484356,0.0000040115137,0.00021027103],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.99774265,0.0016614228,0.000089790185,0.0001936775,0.0001772535,0.00013526104],"domain_scores_gemma":[0.9937941,0.0048808143,0.00088105194,0.00013344077,0.00014564271,0.00016493694],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004628569,0.00095277483,0.001221168,0.0008035881,0.0001515064,0.0010416285,0.0010424898,0.0010348212,0.003082823],"category_scores_gemma":[0.014007947,0.00040794123,0.0029783966,0.00060084986,0.0005102606,0.0008478796,0.0007225668,0.0009833187,0.00016018418],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025712216,0.001014257,0.020444892,0.0011394324,0.0038289393,0.00018902229,0.00007520035,0.8966311,0.0012560196,0.0026776127,0.00071726745,0.046314113],"study_design_scores_gemma":[0.009544687,0.03320299,0.030451957,0.0009795682,0.0074069584,0.0005188149,0.00019885636,0.9048194,0.0032999367,0.00733469,0.0021064489,0.00013565882],"about_ca_topic_score_codex":0.005548856,"about_ca_topic_score_gemma":0.0025297117,"teacher_disagreement_score":0.005548856,"about_ca_system_score_codex":0.0031344765,"about_ca_system_score_gemma":0.001904525,"threshold_uncertainty_score":0.024478495},"labels":[],"label_agreement":null},{"id":"W3193000380","doi":"10.2147/ceor.s304395","title":"Evaluation of the Long-Term Cost-Effectiveness of the Dexcom G6 Continuous Glucose Monitor versus Self-Monitoring of Blood Glucose in People with Type 1 Diabetes in Canada","year":2021,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Diabetes Management and Research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Dexcom","keywords":"Fingerstick; Medicine; Continuous glucose monitoring; Hypoglycemia; Glycemic; Type 1 diabetes; Life expectancy; Type 2 diabetes; Blood Glucose Self-Monitoring; Diabetes mellitus; Emergency medicine; Intensive care medicine; Endocrinology; Environmental health; Population","score_opus":0.07250680510475792,"score_gpt":0.39753152082730214,"score_spread":0.3250247157225442,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3193000380","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94693047,0.017618353,0.001552893,0.002941611,0.00017440549,0.0029766378,0.014751428,0.000055774555,0.012998333],"genre_scores_gemma":[0.9915799,0.002834361,0.001658662,0.00034445565,0.000023824206,0.0002868968,0.0024406705,0.00000885335,0.00082237157],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967229,0.0013510624,0.00019762512,0.00022386985,0.0008865741,0.00061796],"domain_scores_gemma":[0.995713,0.0014349556,0.0005697594,0.000090233705,0.0013874762,0.0008045795],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0049391706,0.0009098142,0.001490659,0.0012962408,0.00090984796,0.0017481195,0.0017620516,0.0008898218,0.003242747],"category_scores_gemma":[0.01456569,0.0003576504,0.0037454546,0.002494731,0.0006615136,0.00063847116,0.0011031837,0.0013005666,0.00013471424],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14266823,0.0077464865,0.31527066,0.013431283,0.020863285,0.00077343616,0.0005390197,0.24487846,0.0017941698,0.010771873,0.01731842,0.22394472],"study_design_scores_gemma":[0.03664908,0.04331606,0.51488554,0.005135185,0.026301464,0.0007713231,0.0021013096,0.34633428,0.002363233,0.0040177926,0.017631628,0.00049305207],"about_ca_topic_score_codex":0.9202501,"about_ca_topic_score_gemma":0.91540605,"teacher_disagreement_score":0.08228642,"about_ca_system_score_codex":0.08228642,"about_ca_system_score_gemma":0.064993456,"threshold_uncertainty_score":0.59703255},"labels":[],"label_agreement":null},{"id":"W3207707436","doi":"10.2147/ceor.s330118","title":"Cost-Effectiveness of Repository Corticotropin Injection for the Treatment of Acute Exacerbations in Multiple Sclerosis","year":2021,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Mallinckrodt Pharmaceuticals","keywords":"Medicine; Multiple sclerosis; Pediatrics; Internal medicine; Immunology","score_opus":0.32486510438298205,"score_gpt":0.4743038505719606,"score_spread":0.14943874618897857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3207707436","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93871415,0.022809777,0.01925656,0.004130308,0.00023775398,0.0012268052,0.0025581387,0.00018141701,0.010885057],"genre_scores_gemma":[0.99713755,0.0010393453,0.0011534527,0.000105991974,0.00001445991,0.00009869255,0.00020658702,0.0000050017215,0.00023878827],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9977677,0.0016082915,0.00008181981,0.00012695942,0.00026534914,0.00014986178],"domain_scores_gemma":[0.9901219,0.00822345,0.0009540155,0.00013500771,0.0002555895,0.00031002905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0052022142,0.000938433,0.0011511127,0.0008872629,0.0002560743,0.0014778045,0.0009798276,0.0010902492,0.0041633607],"category_scores_gemma":[0.015091059,0.00048322452,0.0029377397,0.00065941503,0.0005206716,0.0009591217,0.0007674017,0.001616456,0.00016905915],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0142096905,0.0006498818,0.016043212,0.0010681901,0.0035950413,0.00026706155,0.000059090416,0.91990334,0.0006121977,0.0044200327,0.0012780711,0.037894167],"study_design_scores_gemma":[0.005418725,0.007582759,0.025072418,0.0011489188,0.007043221,0.0006387885,0.00016679517,0.93741727,0.0015209478,0.011561236,0.0023103722,0.00011850762],"about_ca_topic_score_codex":0.010582694,"about_ca_topic_score_gemma":0.0051548965,"teacher_disagreement_score":0.010582694,"about_ca_system_score_codex":0.005810471,"about_ca_system_score_gemma":0.003106609,"threshold_uncertainty_score":0.042158127},"labels":[],"label_agreement":null},{"id":"W3216182527","doi":"10.2147/ceor.s336915","title":"Cost-Effectiveness of Once-Daily, Single-Inhaler Indacaterol Acetate/ Glycopyrronium Bromide/ Mometasone Furoate in Patients with Uncontrolled Moderate-to-Severe Asthma in Canada","year":2021,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; Novartis (Canada)","funders":"Novartis Pharma","keywords":"Medicine; Indacaterol; Mometasone furoate; Fluticasone propionate; Asthma; Salmeterol; Exacerbation; Inhaler; Cost effectiveness; Internal medicine; Dry-powder inhaler; Corticosteroid; Bronchodilator","score_opus":0.05274054645496132,"score_gpt":0.35609865220691533,"score_spread":0.303358105751954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3216182527","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99183017,0.0015737691,0.00060716,0.0012145216,0.000027963233,0.00023455454,0.002428603,0.000023099861,0.002060036],"genre_scores_gemma":[0.99825364,0.00030203778,0.0003577963,0.00010246999,0.000006125047,0.000022208164,0.0006197472,0.0000027385565,0.0003331849],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.99916697,0.00028058022,0.00003579401,0.00009602132,0.00013255833,0.0002880328],"domain_scores_gemma":[0.9979664,0.0007907922,0.00036773662,0.00004531305,0.00027501438,0.0005546909],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012360582,0.00058324344,0.0008523981,0.0005747251,0.0006899501,0.0011933668,0.0013715181,0.0008411185,0.002452496],"category_scores_gemma":[0.0054199523,0.0005273062,0.0021195032,0.00071144284,0.0006446258,0.00044840088,0.00059468707,0.0009731255,0.00008647507],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02452591,0.001787964,0.29476172,0.0011033957,0.00449316,0.0009544761,0.00020104891,0.6307731,0.0014428098,0.003986369,0.0059939716,0.029976072],"study_design_scores_gemma":[0.009031766,0.0028687324,0.19746491,0.0004101926,0.0036493135,0.0005625797,0.00052942795,0.78010404,0.0010458892,0.0018051314,0.0023628862,0.00016513979],"about_ca_topic_score_codex":0.9386889,"about_ca_topic_score_gemma":0.91973454,"teacher_disagreement_score":0.061311126,"about_ca_system_score_codex":0.04274831,"about_ca_system_score_gemma":0.03722361,"threshold_uncertainty_score":0.31016213},"labels":[],"label_agreement":null},{"id":"W4205403076","doi":"10.2147/ceor.s340385","title":"Issue with Evaluating Costs Over Time in a Context of Medical Guideline Changes: An Example in Myocardial Infarction Care Based on a Longitudinal Study from 1997 to 2018","year":2022,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Acute Myocardial Infarction Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université du Québec à Montréal; Université du Québec à Trois-Rivières; Centre hospitalier de l'Université Laval; Université du Québec à Rimouski; Institut universitaire de cardiologie et de pneumologie de Québec; Université Laval","funders":"","keywords":"Context (archaeology); Myocardial infarction; Longitudinal study; Guideline; Health care; Medical care","score_opus":0.1787159488843767,"score_gpt":0.49802267511247633,"score_spread":0.31930672622809964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205403076","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9844285,0.0019241903,0.0012028936,0.0057730167,0.00007517559,0.00006963182,0.0046264296,0.000010593487,0.0018894987],"genre_scores_gemma":[0.99592674,0.00031498715,0.0011144485,0.00054174266,0.00006441527,0.0000932675,0.0017265684,0.0000098721675,0.00020785813],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98817134,0.0070240432,0.0012939285,0.00082603813,0.0018266694,0.0008579434],"domain_scores_gemma":[0.9410281,0.019714683,0.021283362,0.003735487,0.01233477,0.0019035765],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.021713883,0.00040551656,0.00051501504,0.0023395168,0.0014035846,0.0021665494,0.0015029,0.00091455394,0.0010659787],"category_scores_gemma":[0.052579653,0.00023266088,0.0016254776,0.005438437,0.00088415423,0.001867669,0.0015477916,0.0014572026,0.0001579719],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009232236,0.000037383732,0.9943474,0.000031628944,0.000179885,0.000090694055,0.0004937908,0.00024984588,0.000031894073,0.00022183468,0.00092644163,0.0032968211],"study_design_scores_gemma":[0.0000068320473,0.00005996263,0.9965503,0.00006241059,0.00008959705,0.0001260892,0.0009981244,0.0009314936,0.00005497089,0.00016419307,0.00094315526,0.0000129229775],"about_ca_topic_score_codex":0.34316248,"about_ca_topic_score_gemma":0.4625172,"teacher_disagreement_score":0.97828615,"about_ca_system_score_codex":0.0072650816,"about_ca_system_score_gemma":0.0057650246,"threshold_uncertainty_score":0.68233013},"labels":[],"label_agreement":null},{"id":"W4205946049","doi":"10.2147/ceor.s341896","title":"Treatment Outcomes of High-Risk Non-Muscle Invasive Bladder Cancer (HR-NMIBC) in Real-World Evidence (RWE) Studies: Systematic Literature Review (SLR)","year":2022,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Pfizer","keywords":"Bladder cancer; Systematic review; Discontinuation; Generalization; MEDLINE; Cancer survival; Patient data; Overall survival","score_opus":0.15233066222282354,"score_gpt":0.48595328997153875,"score_spread":0.3336226277487152,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205946049","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019548535,0.9964122,0.00023760817,0.0003028893,0.00008863092,0.00036158154,0.00043181708,0.00000622555,0.00020427819],"genre_scores_gemma":[0.051332273,0.9439117,0.0017218569,0.00097206555,0.00016342319,0.0013000475,0.00050203793,0.000009299721,0.00008734801],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9730243,0.010273734,0.011325314,0.0016181846,0.0032449747,0.0005135439],"domain_scores_gemma":[0.9055211,0.06983104,0.017246414,0.0013454703,0.00561356,0.00044243576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.025466995,0.0017818004,0.010273405,0.012404236,0.00074703066,0.0038837958,0.0018883519,0.002434983,0.0030743114],"category_scores_gemma":[0.097352766,0.0012407564,0.014679965,0.012156585,0.0011696924,0.0027996914,0.0019138894,0.0018240868,0.0002095232],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024255525,0.000026326248,0.0021560509,0.94687563,0.031149833,0.00006942634,0.00016243597,0.000117742704,0.000096780765,0.00019052239,0.000602792,0.018309867],"study_design_scores_gemma":[0.00040637018,0.00030750685,0.007990614,0.76226985,0.21913636,0.00033209697,0.00038292407,0.00014087139,0.00024681998,0.0004166678,0.008316562,0.0000534537],"about_ca_topic_score_codex":0.0065858588,"about_ca_topic_score_gemma":0.01955712,"teacher_disagreement_score":0.025466995,"about_ca_system_score_codex":0.0044444515,"about_ca_system_score_gemma":0.0133736525,"threshold_uncertainty_score":0.13468397},"labels":[],"label_agreement":null},{"id":"W4211057148","doi":"10.2147/ceor.s346736","title":"Sensor-Based Technology: Bringing Value to People with Diabetes and the Healthcare System in an Evolving World","year":2022,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Mobile Health and mHealth Applications","field":"Health Professions","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Abbott Diabetes Care","keywords":"Telemedicine; Healthcare system; Value (mathematics); Diabetes mellitus; Continuous glucose monitoring; Quality (philosophy); Diabetes treatment","score_opus":0.07887705250147578,"score_gpt":0.4857573155308227,"score_spread":0.4068802630293469,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4211057148","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.18398353,0.21611077,0.021459877,0.40250364,0.0046190633,0.00023572468,0.0009796838,0.0006804729,0.16942726],"genre_scores_gemma":[0.80961263,0.11325524,0.02178294,0.041263197,0.0030139117,0.00013225897,0.00035704783,0.00007208008,0.01051068],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.996815,0.0016262828,0.00015950002,0.00014260614,0.0010159796,0.0002406076],"domain_scores_gemma":[0.99480635,0.002881414,0.00055954675,0.000307437,0.00082922773,0.0006161495],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037387349,0.0003130262,0.0002690648,0.0009739306,0.0011260514,0.005340649,0.0005003845,0.001682386,0.0071223797],"category_scores_gemma":[0.007021713,0.00014896513,0.00040357272,0.0013633423,0.002251423,0.0048316745,0.0029285664,0.001336401,0.00076788524],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019590043,0.0002065188,0.038762376,0.0028600744,0.0001733656,0.00049962394,0.0049700025,0.0002890707,0.0023015954,0.020921543,0.060562477,0.86825746],"study_design_scores_gemma":[0.000083527804,0.00088431884,0.07171618,0.007813891,0.00042275185,0.0031839837,0.023981871,0.0008639922,0.005685128,0.054792035,0.83043784,0.00013443978],"about_ca_topic_score_codex":0.0035370707,"about_ca_topic_score_gemma":0.0055585373,"teacher_disagreement_score":0.0071223797,"about_ca_system_score_codex":0.0014969299,"about_ca_system_score_gemma":0.0037229392,"threshold_uncertainty_score":0.023826718},"labels":[],"label_agreement":null},{"id":"W4221029596","doi":"10.2147/ceor.s348138","title":"Health-Related Quality of Life of Patients Presenting to the Emergency Department with a Musculoskeletal Disorder","year":2022,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Musculoskeletal pain and rehabilitation","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"HEC Montréal; Centre hospitalier de l'Université Laval; Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal; Centre for Interdisciplinary Research in Rehabilitation; Université Laval; Centre Intégré Universitaire de Santé et de Services Sociaux du Saguenay–Lac-Saint-Jean","funders":"Canadian Institutes of Health Research; Université Laval","keywords":"Emergency department; Quality of life (healthcare); Musculoskeletal pain; Musculoskeletal disorder; Musculoskeletal injury","score_opus":0.05618692627382284,"score_gpt":0.4324110061625774,"score_spread":0.37622407988875456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4221029596","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986304,0.00052831665,0.000052383868,0.00007315225,0.000010755255,0.00006027116,0.00040858838,0.0000014224793,0.00023478792],"genre_scores_gemma":[0.99924374,0.00011148887,0.00009910987,0.0000669925,0.000014355326,0.00008255839,0.00033550584,4.9778805e-7,0.00004557104],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988154,0.0006109768,0.00015370967,0.0001287816,0.00015066263,0.00014047346],"domain_scores_gemma":[0.9971419,0.00075479574,0.0013252991,0.00007479251,0.0002378629,0.0004653591],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017835024,0.00022964986,0.0007232585,0.00060633256,0.00028746325,0.00045017203,0.00022400463,0.000387871,0.0018020767],"category_scores_gemma":[0.0044365823,0.00015435836,0.0007481602,0.00067139365,0.00028603425,0.00043844458,0.00046955672,0.00068340206,0.0001534004],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035382484,0.001140543,0.988561,0.00020770218,0.00043935928,0.000077378725,0.00016479212,0.00015540961,0.00020070821,0.000019406529,0.00034643104,0.00514911],"study_design_scores_gemma":[0.00060669833,0.0057417303,0.99224114,0.000041952226,0.00017658825,0.00024319727,0.0002473809,0.00020191548,0.00010325076,0.000041664272,0.000338551,0.000015981414],"about_ca_topic_score_codex":0.0005518989,"about_ca_topic_score_gemma":0.0007630781,"teacher_disagreement_score":0.0018020767,"about_ca_system_score_codex":0.00036455845,"about_ca_system_score_gemma":0.00037829587,"threshold_uncertainty_score":0.009432197},"labels":[],"label_agreement":null},{"id":"W4225728238","doi":"10.2147/ceor.s360741","title":"Clinical and Economic Benefits of Lenzilumab Plus Standard of Care Compared with Standard of Care Alone for the Treatment of Hospitalized Patients with Coronavirus Disease 19 (COVID-19) from the Perspective of National Health Service England","year":2022,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"COVID-19 Clinical Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Standard of care; Perspective (graphical); Coronavirus disease 2019 (COVID-19); National standard; Disease; Coronavirus; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","score_opus":0.15323440834654267,"score_gpt":0.5107666465830766,"score_spread":0.3575322382365339,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225728238","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9532376,0.026622018,0.003977017,0.002163457,0.00021046448,0.0008484841,0.0057882755,0.00006410129,0.007088586],"genre_scores_gemma":[0.99423814,0.0022853662,0.0015145681,0.000188302,0.0000276492,0.00017667773,0.0012111795,0.0000069132816,0.00035117834],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9955929,0.003025616,0.00025149167,0.00029681125,0.0005510912,0.0002821751],"domain_scores_gemma":[0.99555653,0.0025390934,0.0012226421,0.0000986919,0.00030911228,0.00027388523],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0045620715,0.0009360358,0.0011297582,0.0013588262,0.00016938265,0.0015002514,0.0006551672,0.000830475,0.0026089512],"category_scores_gemma":[0.014713266,0.00040879342,0.0035869463,0.001239601,0.00045986907,0.0011889061,0.0010929711,0.0010539592,0.00016889318],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07293845,0.0015091622,0.26517352,0.010449461,0.026544936,0.0012582921,0.00040259562,0.40467572,0.0019001084,0.010340644,0.009673116,0.19513406],"study_design_scores_gemma":[0.022092272,0.036517445,0.5002423,0.0066150315,0.029858872,0.003092558,0.0011501544,0.36574256,0.003880724,0.011666922,0.01877031,0.000370805],"about_ca_topic_score_codex":0.011996064,"about_ca_topic_score_gemma":0.009394503,"teacher_disagreement_score":0.011996064,"about_ca_system_score_codex":0.005007119,"about_ca_system_score_gemma":0.0020191148,"threshold_uncertainty_score":0.03632933},"labels":[],"label_agreement":null},{"id":"W4285744912","doi":"10.2147/ceor.s338225","title":"Economic Burden of COVID-19: A Systematic Review","year":2022,"lang":"en","type":"review","venue":"ClinicoEconomics and Outcomes Research","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":195,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Héma-Québec","funders":"","keywords":"Medicine; MEDLINE; Psychological intervention; Cochrane Library; Systematic review; Population; Pandemic; Health care; Coronavirus disease 2019 (COVID-19); Data extraction; Productivity; Environmental health; Meta-analysis; Pathology; Disease; Infectious disease (medical specialty); Nursing","score_opus":0.45678125092406846,"score_gpt":0.6258804148379368,"score_spread":0.1690991639138683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285744912","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010244735,0.9964244,0.00019104952,0.00078672124,0.00021391817,0.00047677642,0.0005493685,0.0000080031605,0.0003252088],"genre_scores_gemma":[0.023993934,0.97164506,0.00115439,0.0012104587,0.00022613666,0.0011866557,0.00043878093,0.0000087805865,0.00013585738],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.97848344,0.008413125,0.0068965023,0.0010994545,0.0044821175,0.00062532426],"domain_scores_gemma":[0.9243967,0.054975793,0.013779406,0.0008684817,0.0053651845,0.0006144284],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.019512085,0.002142931,0.009111187,0.017228102,0.0008506946,0.0045854175,0.002161895,0.0029667797,0.004938705],"category_scores_gemma":[0.09066254,0.0015767599,0.00951012,0.013332209,0.0012797383,0.0035470156,0.0023490333,0.0019217838,0.0003009398],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016887166,0.000012396617,0.00084548554,0.96701306,0.011373124,0.00009898033,0.00010180879,0.00012114551,0.00006690309,0.00033004917,0.0016677601,0.018200474],"study_design_scores_gemma":[0.00017650408,0.00011787077,0.0028713846,0.94065624,0.04482289,0.00026632214,0.00020888083,0.00011035205,0.00008395349,0.00043454987,0.010222339,0.0000287024],"about_ca_topic_score_codex":0.0075669824,"about_ca_topic_score_gemma":0.019624352,"teacher_disagreement_score":0.019512085,"about_ca_system_score_codex":0.0077900807,"about_ca_system_score_gemma":0.01935045,"threshold_uncertainty_score":0.10319102},"labels":[],"label_agreement":null},{"id":"W4322744955","doi":"10.2147/ceor.s397671","title":"Comprehensive Custom-Pak® in Cataract and Vitreoretinal Surgery in Canadian Hospitals: Time and Budget Impact Analysis","year":2023,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Healthcare Operations and Scheduling Optimization","field":"Health Professions","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alcon (Canada); Kensington Health","funders":"","keywords":"Medicine; Cataract surgery; Operations management; Medical emergency; Surgery; Engineering","score_opus":0.12812742681287384,"score_gpt":0.5417005292994408,"score_spread":0.413573102486567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322744955","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94469124,0.003678831,0.005868887,0.00186131,0.0000597355,0.000908689,0.020655375,0.00010531797,0.022170737],"genre_scores_gemma":[0.98278445,0.0018746591,0.0057143727,0.00014559003,0.000013368037,0.00018859949,0.006793614,0.00001875376,0.002466465],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.99666154,0.00055214704,0.0001314131,0.0002700637,0.0011947834,0.0011901289],"domain_scores_gemma":[0.9951664,0.0013054238,0.0007186761,0.00014592521,0.0020301554,0.0006333343],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036552674,0.0011687189,0.0007869491,0.0038931891,0.0013553726,0.0026638347,0.0015550472,0.000730353,0.003152413],"category_scores_gemma":[0.009321961,0.00066810515,0.002167463,0.007541214,0.00059705303,0.00094522367,0.0012366906,0.0010669063,0.0001764328],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006831682,0.00040997693,0.29704425,0.0006827722,0.00080864475,0.00032116286,0.0003842561,0.639556,0.00046841023,0.009739237,0.0079421215,0.041960068],"study_design_scores_gemma":[0.00018624197,0.00059275754,0.4893379,0.00044711717,0.00080828223,0.00014716812,0.002019547,0.4872663,0.00071535027,0.0017499027,0.016534906,0.00019454009],"about_ca_topic_score_codex":0.9848995,"about_ca_topic_score_gemma":0.97922975,"teacher_disagreement_score":0.12385948,"about_ca_system_score_codex":0.12385948,"about_ca_system_score_gemma":0.073104925,"threshold_uncertainty_score":0.89866763},"labels":[],"label_agreement":null},{"id":"W4323568228","doi":"10.2147/ceor.s397154","title":"Glucarpidase for Treating Adults with Delayed Methotrexate Elimination Due to Impaired Renal Function: An Economic Simulation Analysis","year":2023,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Reimbursement; Intensive care medicine; Renal function; Pharmacology; Internal medicine; Health care","score_opus":0.07081217146715012,"score_gpt":0.44605899172921887,"score_spread":0.37524682026206874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4323568228","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9474938,0.001974868,0.025535231,0.0020992195,0.000100335004,0.00083362387,0.0031286275,0.00006454656,0.018769702],"genre_scores_gemma":[0.98842156,0.0010422675,0.007489044,0.00016426947,0.000019710522,0.0004119342,0.0007715255,0.00001000509,0.001669774],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9988887,0.000716595,0.000038817805,0.00007678014,0.00010205782,0.00017706573],"domain_scores_gemma":[0.98989516,0.008439079,0.0005681126,0.00010784723,0.0005529426,0.00043693004],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003228529,0.0011838339,0.0014270493,0.0018412136,0.0006091723,0.0016032853,0.0012292665,0.0018030625,0.005260263],"category_scores_gemma":[0.0077463617,0.0006140241,0.002538276,0.001773996,0.00046427033,0.0011323144,0.0008846936,0.0016773152,0.0001756521],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004346637,0.0002209127,0.003440812,0.00012536468,0.00013312662,0.00011929776,0.000023509365,0.9901288,0.00010783082,0.0020675282,0.00053297414,0.0026651847],"study_design_scores_gemma":[0.00021920759,0.00041643323,0.0015595359,0.00006666106,0.00020122278,0.00005034116,0.00008649723,0.99546707,0.00011688139,0.0012115142,0.0005860582,0.000018571422],"about_ca_topic_score_codex":0.048041455,"about_ca_topic_score_gemma":0.027829606,"teacher_disagreement_score":0.048041455,"about_ca_system_score_codex":0.006012811,"about_ca_system_score_gemma":0.005187193,"threshold_uncertainty_score":0.095523655},"labels":[],"label_agreement":null},{"id":"W4362721751","doi":"10.2147/ceor.s401003","title":"Holistic View of Autografting Patients by Percentage of Total Body Surface Area Burned: Medical Record Abstraction Integrated with Administrative Claims","year":2023,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Burn Injury Management and Outcomes","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Mallinckrodt Pharmaceuticals","keywords":"Medical record; Medicine; Total body surface area; Documentation; Retrospective cohort study; Observational study; Health care; Cohort; Diabetes mellitus; Emergency medicine; Population; Medical emergency; Surgery; Internal medicine; Environmental health","score_opus":0.12201657164370706,"score_gpt":0.4517683984514093,"score_spread":0.32975182680770226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362721751","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895169,0.0006312999,0.0010188828,0.00033995588,0.000012756146,0.00016675156,0.0072644013,0.00001721841,0.00103192],"genre_scores_gemma":[0.9935029,0.000314449,0.0011680373,0.00012083566,0.000032521424,0.00013336261,0.004595941,0.0000048637785,0.00012706257],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99322516,0.0023653114,0.0018805753,0.000741687,0.0013207017,0.0004665674],"domain_scores_gemma":[0.9817222,0.003364069,0.011162477,0.0012960368,0.0017901792,0.0006649873],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004131556,0.00028537886,0.0006790555,0.0045704697,0.0005613455,0.0017334941,0.0005586147,0.0003776489,0.0013601065],"category_scores_gemma":[0.014674048,0.0003393513,0.0006399729,0.005941934,0.0003767519,0.0014856063,0.001873694,0.00063105725,0.00029543162],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007091955,0.000037819795,0.9954085,0.00006446944,0.00006517844,0.0000816265,0.0006371959,0.000046606132,0.000112840906,0.000046538044,0.00026830492,0.0031599288],"study_design_scores_gemma":[0.000007649374,0.00010992343,0.9958288,0.000079670084,0.000057232603,0.0003230013,0.0021372815,0.0004501684,0.0001630856,0.00007167795,0.0007589637,0.000012589251],"about_ca_topic_score_codex":0.0065490613,"about_ca_topic_score_gemma":0.007274652,"teacher_disagreement_score":0.0065490613,"about_ca_system_score_codex":0.00080334116,"about_ca_system_score_gemma":0.0014319795,"threshold_uncertainty_score":0.02184999},"labels":[],"label_agreement":null},{"id":"W4366588956","doi":"10.2147/ceor.s377935","title":"Cost-Effectiveness of Icosapent Ethyl (IPE) for the Reduction of the Risk of Ischemic Cardiovascular Events in Canada","year":2023,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Montreal Heart Institute; St. Michael's Hospital; Robarts Clinical Trials; Université de Montréal","funders":"HLS Therapeutics; Amryt Pharma; Sanofi; Kowa Company; Regeneron Pharmaceuticals; Novo Nordisk; Servier; Amgen; Pfizer; Esperion Therapeutics; Ultragenyx Pharmaceutical; AstraZeneca; Eli Lilly and Company","keywords":"Medicine; Bioinformatics; Biology","score_opus":0.10892320106107337,"score_gpt":0.413451090303862,"score_spread":0.3045278892427886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4366588956","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8995619,0.02993864,0.0072231856,0.010434273,0.00020632175,0.0017536245,0.021673294,0.0002576802,0.028951071],"genre_scores_gemma":[0.99129736,0.0036471316,0.0018912023,0.00036606257,0.000013697922,0.0000924053,0.0016972985,0.00001361722,0.0009811658],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.99795747,0.00079168536,0.00010813638,0.00016316993,0.0005718298,0.00040769088],"domain_scores_gemma":[0.99648356,0.001568104,0.0003531035,0.000084516185,0.0011010439,0.00040968455],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002520381,0.000773078,0.0009123755,0.0011059896,0.000947527,0.0015632027,0.0016368141,0.0008140749,0.0037016883],"category_scores_gemma":[0.01145049,0.00047426258,0.0021107623,0.0017034165,0.00072582497,0.00049446983,0.00082968845,0.0011156624,0.000102401646],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019743185,0.0012936501,0.09880842,0.004770381,0.006053022,0.0009153463,0.00032228,0.6886804,0.0015836951,0.018950498,0.024293013,0.1345862],"study_design_scores_gemma":[0.012485641,0.003815106,0.17656891,0.0021035827,0.008187396,0.00065678597,0.00096423324,0.7646494,0.002145812,0.009740161,0.018280325,0.00040268427],"about_ca_topic_score_codex":0.98276293,"about_ca_topic_score_gemma":0.9797968,"teacher_disagreement_score":0.08296621,"about_ca_system_score_codex":0.08296621,"about_ca_system_score_gemma":0.096940644,"threshold_uncertainty_score":0.60196483},"labels":[],"label_agreement":null},{"id":"W4381988377","doi":"10.2147/ceor.s410082","title":"Acthar Gel (RCI): A Narrative Literature Review of Clinical and Economic Evidence","year":2023,"lang":"en","type":"review","venue":"ClinicoEconomics and Outcomes Research","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Mallinckrodt Pharmaceuticals","keywords":"Medicine; Sarcoidosis; Internal medicine; Infliximab; Polymyositis; Dermatomyositis; Rheumatoid arthritis; Disease","score_opus":0.3911887662179583,"score_gpt":0.6079644652209814,"score_spread":0.21677569900302307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4381988377","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017562676,0.9985683,0.000045036428,0.0004689843,0.00009178813,0.0000321925,0.00017154153,0.0000033911008,0.0004431734],"genre_scores_gemma":[0.0018031449,0.99724305,0.0001649358,0.00044668652,0.00010669112,0.000052607716,0.00011087479,0.0000018682778,0.00007007839],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9978592,0.00053815905,0.00078476005,0.0002042372,0.00052091706,0.000092792376],"domain_scores_gemma":[0.987263,0.009025931,0.0023233348,0.00011923015,0.0010978577,0.00017070546],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034619016,0.0012736456,0.0035035652,0.010117189,0.0004812275,0.0027477697,0.0015760582,0.0016633826,0.009918366],"category_scores_gemma":[0.015870493,0.0005704122,0.0025544225,0.011045809,0.0006809455,0.0021995427,0.001301012,0.0013515126,0.0008548957],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000400433,0.00005737704,0.0006545141,0.6286343,0.0016025547,0.0002635194,0.00014447607,0.00026598517,0.000188717,0.002348995,0.018267572,0.34717157],"study_design_scores_gemma":[0.00019674894,0.0002510723,0.0032641417,0.7978687,0.010261156,0.0014221049,0.00032725607,0.00016722105,0.000172383,0.0017654595,0.18424919,0.000054603228],"about_ca_topic_score_codex":0.003321059,"about_ca_topic_score_gemma":0.0062439064,"teacher_disagreement_score":0.010117189,"about_ca_system_score_codex":0.0025555757,"about_ca_system_score_gemma":0.006995543,"threshold_uncertainty_score":0.033180237},"labels":[],"label_agreement":null},{"id":"W4386513946","doi":"10.2147/ceor.s416562","title":"The Cost of Maternal Complications and Its Associated Factors Among Mothers Attending Public Hospitals in Harari Region and Dire Dawa City Administration, Eastern Ethiopia: An Institution-Based Cross-Sectional Study","year":2023,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Global Maternal and Child Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Haramaya University","keywords":"Medicine; Cross-sectional study; Public health; Health facility; Family medicine; Pediatrics; Demography; Environmental health; Health services; Nursing; Population","score_opus":0.2003615287841409,"score_gpt":0.47434215941726776,"score_spread":0.27398063063312683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386513946","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99949396,0.00015089718,0.000021734651,0.000021311705,0.0000015935364,0.000011162197,0.00015804736,4.94848e-7,0.00014085339],"genre_scores_gemma":[0.9994398,0.0002343069,0.00007128022,0.000024601504,0.0000036554804,0.000017996235,0.00011783297,4.2753263e-7,0.00009013053],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99954337,0.00015214724,0.000079164834,0.000062170264,0.000083806975,0.00007943648],"domain_scores_gemma":[0.99892515,0.0002745031,0.00053400896,0.000045270495,0.00010342398,0.000117617965],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00090285344,0.00023276581,0.00031438822,0.0008719512,0.00047910446,0.00073958,0.00034438618,0.0003322129,0.0010969981],"category_scores_gemma":[0.0017896208,0.00042408583,0.00035234287,0.0011628706,0.00023449215,0.0006067759,0.0004317338,0.00045978095,0.0001437836],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027505404,0.000059461556,0.99890983,0.00002024975,0.00002161458,0.00010352759,0.00024019979,0.000014418119,0.000053305976,0.000013063428,0.00004169213,0.00049515255],"study_design_scores_gemma":[0.0000032637008,0.00013360253,0.99696785,0.000030485064,0.000026004578,0.0003819605,0.002184232,0.0000906406,0.000036399128,0.000013062935,0.000128366,0.0000041660883],"about_ca_topic_score_codex":0.0050939787,"about_ca_topic_score_gemma":0.007415291,"teacher_disagreement_score":0.0050939787,"about_ca_system_score_codex":0.00067851535,"about_ca_system_score_gemma":0.00042975566,"threshold_uncertainty_score":0.010128677},"labels":[],"label_agreement":null},{"id":"W4387710816","doi":"10.2147/ceor.s428466","title":"Cost-Effectiveness of Acthar Gel versus Standard of Care for the Treatment of Advanced Symptomatic Sarcoidosis","year":2023,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Sarcoidosis and Beryllium Toxicity Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Mallinckrodt Pharmaceuticals","keywords":"Medicine; Cohort; Sarcoidosis; Health care; Internal medicine","score_opus":0.22108551711672444,"score_gpt":0.5209349341320468,"score_spread":0.2998494170153224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387710816","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9500388,0.034281388,0.0044006617,0.0018265685,0.00035467677,0.0010628109,0.0018163417,0.00009971779,0.006119023],"genre_scores_gemma":[0.9970368,0.0013605586,0.00078473875,0.00015171028,0.00003822092,0.00015596968,0.00032917512,0.0000038266235,0.0001389511],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9960461,0.0028343538,0.00022557359,0.00030151967,0.0003565517,0.00023577677],"domain_scores_gemma":[0.99436367,0.004001421,0.0009557982,0.00012600032,0.00016093018,0.00039212563],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004992686,0.00073645206,0.0017227951,0.0010000784,0.00016407041,0.001496476,0.00077919377,0.0011629565,0.0038763299],"category_scores_gemma":[0.01179943,0.00031567036,0.005146545,0.00064880383,0.00049300195,0.0010937601,0.00083523476,0.001488254,0.00016181188],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3256978,0.005058768,0.0534805,0.01078567,0.028307127,0.0006019226,0.00032680744,0.26666236,0.0029991122,0.009189628,0.0047899107,0.29210037],"study_design_scores_gemma":[0.08219596,0.18022306,0.17350243,0.008830797,0.05280962,0.0031317535,0.0009267741,0.4600372,0.0046597333,0.02251486,0.010790608,0.0003772061],"about_ca_topic_score_codex":0.0024311163,"about_ca_topic_score_gemma":0.0014528338,"teacher_disagreement_score":0.004992686,"about_ca_system_score_codex":0.002574813,"about_ca_system_score_gemma":0.001509918,"threshold_uncertainty_score":0.026404142},"labels":[],"label_agreement":null},{"id":"W4390826881","doi":"10.2147/ceor.s434971","title":"Exploring the Cost-Utility of a Biomarker Predicting Persistent Severe Acute Kidney Injury: The Case of C-C Motif Chemokine Ligand 14 (CCL14)","year":2024,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Acute Kidney Injury Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Health Economics","funders":"Baxter Healthcare Corporation","keywords":"Medicine; Acute kidney injury; Cohort; Intensive care medicine; Quality-adjusted life year; Dialysis; Emergency medicine; Cost effectiveness; Internal medicine","score_opus":0.2368819059464225,"score_gpt":0.45608396091265435,"score_spread":0.21920205496623185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390826881","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911771,0.00059980503,0.0065366793,0.00045118527,0.000017642924,0.00010959752,0.0005089887,0.0000138999685,0.0005852767],"genre_scores_gemma":[0.99790597,0.00010425221,0.0015986277,0.00003999524,0.000010356039,0.000036887566,0.00019330799,0.0000031718794,0.00010749508],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9931376,0.005299486,0.00019724242,0.00065585866,0.0002821436,0.000427716],"domain_scores_gemma":[0.93326473,0.060790572,0.0031735047,0.0010823875,0.0010161086,0.0006727231],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015388438,0.0012880597,0.0013558458,0.0015620741,0.00046120497,0.001815975,0.001600789,0.0013980804,0.0021112685],"category_scores_gemma":[0.031351108,0.0006402767,0.0046941084,0.0010272616,0.0009503573,0.001313956,0.0014486898,0.0017340248,0.00011617153],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0071027754,0.00080969004,0.20350835,0.0003594009,0.0032769344,0.00039656562,0.000106931635,0.7701499,0.0005606676,0.002853122,0.00036566553,0.010510088],"study_design_scores_gemma":[0.00036635046,0.002410242,0.03934759,0.000091438254,0.0021120722,0.00028973952,0.0001288945,0.94983786,0.0007576078,0.004250703,0.00034940543,0.000058000263],"about_ca_topic_score_codex":0.010854288,"about_ca_topic_score_gemma":0.004712629,"teacher_disagreement_score":0.015388438,"about_ca_system_score_codex":0.0036555664,"about_ca_system_score_gemma":0.0025309369,"threshold_uncertainty_score":0.08138287},"labels":[],"label_agreement":null},{"id":"W4390987140","doi":"10.2147/ceor.s445141","title":"Budget Impact Analysis of Minimally Invasive versus Open Transforaminal Lumbar Interbody Fusion for Lumbar Degenerative Disease: A European Hospital Perspective","year":2024,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Spine and Intervertebral Disc Pathology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Lumbar; Surgery; Blood loss; Degenerative disc disease","score_opus":0.09880828495304093,"score_gpt":0.5021162951625385,"score_spread":0.4033080102094976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390987140","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.561722,0.23772141,0.052975748,0.02857946,0.0012432489,0.0020726114,0.036722127,0.00022228186,0.07874119],"genre_scores_gemma":[0.97127694,0.014007042,0.005735339,0.0019165176,0.00014735828,0.000714908,0.004611563,0.000045113247,0.001545164],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.990044,0.008297259,0.0002857752,0.00035553056,0.0005288589,0.00048866204],"domain_scores_gemma":[0.99284947,0.004949052,0.0009397424,0.00019278444,0.00068539334,0.00038351762],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009010545,0.0015093804,0.0015341108,0.0020449336,0.00024194454,0.0022610463,0.0010380484,0.0015630851,0.006269448],"category_scores_gemma":[0.021329943,0.0005705647,0.006084597,0.0029024554,0.00040381053,0.00118085,0.0010802097,0.0014712659,0.00032319853],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018660491,0.00073424715,0.031081954,0.0073531964,0.025227768,0.00071197,0.00023645672,0.7506089,0.0009885974,0.03334285,0.019678025,0.11137554],"study_design_scores_gemma":[0.017760681,0.013512437,0.13552555,0.018045833,0.060666233,0.0025516816,0.0019525501,0.56474626,0.0033862528,0.07102187,0.10999866,0.00083198363],"about_ca_topic_score_codex":0.0207717,"about_ca_topic_score_gemma":0.009996879,"teacher_disagreement_score":0.0207717,"about_ca_system_score_codex":0.008218799,"about_ca_system_score_gemma":0.003653245,"threshold_uncertainty_score":0.059631824},"labels":[],"label_agreement":null},{"id":"W4391264145","doi":"10.2147/ceor.s443077","title":"Methods used to account for caregivers’ sex and gender within studies examining the financial burden of caregivers of children and adolescents : Results from a scoping review","year":2024,"lang":"en","type":"review","venue":"ClinicoEconomics and Outcomes Research","topic":"Family Support in Illness","field":"Social Sciences","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bibliothèque et Archives nationales du Québec; Centres Intégré Universitaires de Santé et de Services Sociaux; Université du Québec à Rimouski; Université Laval","funders":"","keywords":"Medicine; MEDLINE; Data extraction; Narrative review; Family medicine","score_opus":0.426790582209805,"score_gpt":0.570804507196553,"score_spread":0.14401392498674798,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391264145","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011582951,0.75815946,0.027548363,0.0076206075,0.0019756835,0.1657201,0.021003176,0.00036712692,0.0060225525],"genre_scores_gemma":[0.061681468,0.41948855,0.09183069,0.0025866276,0.0002897859,0.41691074,0.0055230088,0.00025764387,0.0014315235],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.6612437,0.10941383,0.18853989,0.009013678,0.028564155,0.0032248052],"domain_scores_gemma":[0.4930478,0.38646394,0.065748475,0.012560421,0.040865947,0.0013134767],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.25345853,0.00535829,0.016359476,0.081759825,0.0038818554,0.01348025,0.0068149897,0.005869953,0.012375285],"category_scores_gemma":[0.51395553,0.004563843,0.02521161,0.07625908,0.004626939,0.0129369395,0.011490214,0.003367312,0.001362276],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025376622,0.000021225955,0.0026710532,0.92637295,0.0070961085,0.00027202666,0.0066646733,0.0002322203,0.00028780967,0.0010193284,0.002543754,0.052565143],"study_design_scores_gemma":[0.0002181694,0.00010290213,0.0029415437,0.9466492,0.024154933,0.00022396639,0.0038628546,0.00015483369,0.00038512913,0.0012516262,0.019956186,0.000098590564],"about_ca_topic_score_codex":0.012522494,"about_ca_topic_score_gemma":0.03723613,"teacher_disagreement_score":0.7465415,"about_ca_system_score_codex":0.01573739,"about_ca_system_score_gemma":0.05555353,"threshold_uncertainty_score":0.92061853},"labels":[],"label_agreement":null},{"id":"W4398785298","doi":"10.2147/ceor.s462872","title":"Timeliness of Health Technology Assessments and Price Negotiations for Oncology Drugs in Canada","year":2024,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; Arthur B. McDonald-Canadian Astroparticle Physics Research Institute; University of Ottawa; Wilfrid Laurier University; Fraser Institute; Fraser Health; Canadian Institute for Health Information","funders":"","keywords":"Timeline; Negotiation; Reimbursement; Medicine; Alliance; Family medicine; Agency (philosophy); Public relations; Health care; Political science; Law","score_opus":0.5314994188845462,"score_gpt":0.6262702012041306,"score_spread":0.09477078231958436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4398785298","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5110039,0.16572744,0.010089582,0.059410214,0.0022199599,0.004232355,0.06739422,0.0011186338,0.1788037],"genre_scores_gemma":[0.9511919,0.018776707,0.010003469,0.0023930627,0.0004039102,0.0009625762,0.009252896,0.00014175744,0.0068737627],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.8286017,0.027493723,0.018864345,0.008219895,0.110006005,0.00681435],"domain_scores_gemma":[0.56075263,0.095679976,0.113204844,0.0049962723,0.20122276,0.024143523],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.044578686,0.0005685488,0.0010034613,0.012910527,0.0026385894,0.008551152,0.0025937771,0.0012509396,0.0031580536],"category_scores_gemma":[0.2636517,0.00087536016,0.001676777,0.016479276,0.0009341456,0.0027525784,0.002981359,0.00212128,0.00051424734],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032259487,0.0003380225,0.40607923,0.0131345475,0.002627206,0.0008830109,0.0077749444,0.008008297,0.002640602,0.008715939,0.118599124,0.42797327],"study_design_scores_gemma":[0.00020000564,0.00033419183,0.89169997,0.002122907,0.0004940736,0.00030947602,0.00259203,0.004378504,0.0013693452,0.0005106902,0.09571076,0.00027795564],"about_ca_topic_score_codex":0.8820107,"about_ca_topic_score_gemma":0.9151006,"teacher_disagreement_score":0.9554213,"about_ca_system_score_codex":0.08660029,"about_ca_system_score_gemma":0.17816792,"threshold_uncertainty_score":0.628332},"labels":[],"label_agreement":null},{"id":"W4402533942","doi":"10.2147/ceor.s476426","title":"Adjusting Historical Costs for Inflation with the Use of Standardized Automated Tools","year":2024,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Economic, financial, and policy analysis","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal; Université Laval; Centre hospitalier de l'Université Laval","funders":"Fondation des pompiers du Québec pour les grands brûlés; Réseau Québécois de Recherche sur les Médicaments","keywords":"Medicine; Inflation (cosmology); Data science; Computer science","score_opus":0.30047795636472757,"score_gpt":0.4189119704325253,"score_spread":0.11843401406779774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402533942","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.39569557,0.0029161612,0.53522575,0.002765985,0.0010013689,0.0013611112,0.020149115,0.005474528,0.035410326],"genre_scores_gemma":[0.8308926,0.0007840177,0.15356147,0.0002047344,0.00035074045,0.00072770333,0.00932376,0.0005909301,0.0035640635],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9937943,0.002839388,0.0007590405,0.00079257076,0.0015823647,0.00023226527],"domain_scores_gemma":[0.9667919,0.015294425,0.0075444654,0.005283702,0.0047484594,0.00033708868],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007353428,0.0009642604,0.00084334967,0.005278061,0.00044062285,0.003323756,0.0012012996,0.000701537,0.0063214954],"category_scores_gemma":[0.07480007,0.000582158,0.00085669494,0.0060033905,0.00038711634,0.0019843774,0.0016931236,0.0010043173,0.001637535],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009292332,0.0003894827,0.28977892,0.00035282833,0.0006839811,0.0002631675,0.0004732743,0.1250738,0.0006264311,0.019659735,0.0350243,0.52674484],"study_design_scores_gemma":[0.0002776644,0.00043688575,0.29707664,0.00038549403,0.00024240269,0.0004541576,0.0006358841,0.6121512,0.0029974347,0.04582436,0.039242994,0.00027483297],"about_ca_topic_score_codex":0.020778516,"about_ca_topic_score_gemma":0.01694994,"teacher_disagreement_score":0.020778516,"about_ca_system_score_codex":0.0018027503,"about_ca_system_score_gemma":0.0019841196,"threshold_uncertainty_score":0.04131514},"labels":[],"label_agreement":null},{"id":"W4408692096","doi":"10.2147/ceor.s504462","title":"The Burden of Obesity in Saudi Arabia: A Real-World Cost-of-Illness Study","year":2025,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Bariatric Surgery and Outcomes","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Health Technology Assessment international; Mahidol University; Prince Sattam bin Abdulaziz University","keywords":"Medicine; Obesity; Internal medicine","score_opus":0.08310755098022952,"score_gpt":0.4498267128533429,"score_spread":0.3667191618731134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408692096","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932168,0.0017725024,0.00014763954,0.0006487549,0.000014775495,0.000033502478,0.0037644634,0.0000028137094,0.00039882865],"genre_scores_gemma":[0.9972504,0.00096234854,0.0001416092,0.00006945236,0.000016001091,0.000019369043,0.0014747133,0.000001419242,0.00006463851],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99928206,0.00036707122,0.0000775084,0.00005590387,0.00010455699,0.000112873786],"domain_scores_gemma":[0.9972059,0.0007085673,0.0012803692,0.00010022894,0.00042712703,0.00027776556],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012371583,0.0005849155,0.00041093826,0.0014346787,0.00024296631,0.0009418332,0.0004597906,0.00069860846,0.0017684663],"category_scores_gemma":[0.004272259,0.00024455483,0.0013529834,0.0022802013,0.000283895,0.00067216094,0.0007736444,0.0006159437,0.00014545978],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065603654,0.00016852388,0.98354554,0.00034560857,0.0011922182,0.00045910748,0.0003288941,0.004120428,0.00009419766,0.00053684774,0.0016153572,0.0069372663],"study_design_scores_gemma":[0.00009000772,0.00024551013,0.98210204,0.00026625764,0.00055379135,0.0007134011,0.0016717446,0.012305402,0.00007451669,0.00032422176,0.0016151622,0.000037981154],"about_ca_topic_score_codex":0.07332551,"about_ca_topic_score_gemma":0.041670494,"teacher_disagreement_score":0.07332551,"about_ca_system_score_codex":0.004250383,"about_ca_system_score_gemma":0.0011554032,"threshold_uncertainty_score":0.14579743},"labels":[],"label_agreement":null},{"id":"W4412557155","doi":"10.2147/ceor.s527169","title":"Cost-Utility Analysis of Metabolic Bariatric Surgery for Individuals with Obesity in Saudi Arabia","year":2025,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Bariatric Surgery and Outcomes","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Health Technology Assessment international; Mahidol University; Prince Sattam bin Abdulaziz University","keywords":"Medicine; Obesity; Obesity Surgery; Bioinformatics; Metabolic syndrome; General surgery; Weight loss; Pathology; Gastric bypass; Biology","score_opus":0.11198586571950932,"score_gpt":0.42964525866890035,"score_spread":0.31765939294939105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412557155","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.972072,0.0036977655,0.013980005,0.0014790293,0.00004536715,0.00034588174,0.0038280708,0.0000510024,0.0045007938],"genre_scores_gemma":[0.9959143,0.0005332683,0.0022725707,0.000060982846,0.000007774726,0.00008353024,0.00069823524,0.0000048860657,0.00042452718],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.99890006,0.0007726047,0.00003915794,0.00008432921,0.00009301948,0.00011084813],"domain_scores_gemma":[0.99500823,0.0039211405,0.000433819,0.000108399734,0.0003462081,0.00018223636],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035855302,0.00080228545,0.0008155715,0.0010240884,0.00026519565,0.0011452787,0.0008702501,0.0007259221,0.0033815212],"category_scores_gemma":[0.00901739,0.0003893668,0.0018428487,0.0007220302,0.0003702632,0.00067901314,0.0008821877,0.00084292586,0.00013075222],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015035064,0.00014311649,0.030790688,0.00038559292,0.0007555718,0.00030344405,0.00008257677,0.95127183,0.00031575645,0.0040922468,0.0010008054,0.009354801],"study_design_scores_gemma":[0.00024523304,0.000696004,0.0135842925,0.00021266913,0.0007286562,0.00025821957,0.0002129557,0.9798678,0.00028640503,0.0028736754,0.000994186,0.00004001899],"about_ca_topic_score_codex":0.04333862,"about_ca_topic_score_gemma":0.022865864,"teacher_disagreement_score":0.04333862,"about_ca_system_score_codex":0.005096292,"about_ca_system_score_gemma":0.0032409145,"threshold_uncertainty_score":0.08617276},"labels":[],"label_agreement":null},{"id":"W4413771329","doi":"10.2147/ceor.s522756","title":"Real-World Disability Outcomes Among Patients Treated with Cariprazine vs Other Atypical Antipsychotics as Adjunctive Treatment for Major Depressive Disorder","year":2025,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Treatment of Major Depression","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Psychiatry; Adjunctive treatment; Major depressive disorder; Aripiprazole; Schizophrenia (object-oriented programming); Pediatrics; Internal medicine; Cognition","score_opus":0.04925114078597439,"score_gpt":0.4311459313388048,"score_spread":0.38189479055283043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413771329","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99706143,0.00068750593,0.000053622603,0.00011900359,0.000010379802,0.0000167912,0.0018545187,0.0000019799697,0.00019483012],"genre_scores_gemma":[0.9979995,0.00017291424,0.00007031478,0.000036456364,0.000011955376,0.000018842793,0.001644004,8.701301e-7,0.000045137236],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978758,0.0009936094,0.00029954276,0.0003566515,0.00026871738,0.00020563332],"domain_scores_gemma":[0.99579054,0.0010236183,0.0024719632,0.00013053017,0.00020761693,0.00037580842],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016857265,0.00020738025,0.00058563397,0.0006619321,0.0002345418,0.0008415643,0.00037208694,0.00042784185,0.0012404054],"category_scores_gemma":[0.0073300814,0.00014758648,0.0012572483,0.0010610274,0.0002014635,0.00048517596,0.00054193544,0.00072636537,0.00012386117],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053970963,0.00020891576,0.98581,0.00013813125,0.0014794983,0.000102462844,0.00008943473,0.0007291776,0.00011478764,0.000100059326,0.0007695869,0.0050609214],"study_design_scores_gemma":[0.00026663629,0.0010581827,0.9951498,0.0000651842,0.0005519982,0.00020175306,0.00027577297,0.0018277072,0.000067037436,0.00010673342,0.00041198544,0.000017104354],"about_ca_topic_score_codex":0.00613852,"about_ca_topic_score_gemma":0.007823514,"teacher_disagreement_score":0.00613852,"about_ca_system_score_codex":0.001045475,"about_ca_system_score_gemma":0.0005015762,"threshold_uncertainty_score":0.012205601},"labels":[],"label_agreement":null},{"id":"W4413777371","doi":"10.2147/ceor.s530832","title":"Early Diagnosis and Timely Terlipressin in Hepatorenal Syndrome Improves Projected Outcomes and Lowers Cost","year":2025,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Mallinckrodt Pharmaceuticals; Ultragenyx Pharmaceutical; Gilead Sciences","keywords":"Terlipressin; Hepatorenal syndrome; Medicine; Intensive care medicine; Internal medicine; Cirrhosis","score_opus":0.05124886025677959,"score_gpt":0.4158430063038175,"score_spread":0.3645941460470379,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413777371","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96145135,0.00086096965,0.022316622,0.002723431,0.000044184573,0.00030332548,0.0037168094,0.00007295761,0.008510308],"genre_scores_gemma":[0.995145,0.0002861965,0.0030348555,0.00010998338,0.000008844247,0.00007957871,0.00065125816,0.0000053814515,0.00067879],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.99913424,0.0005390955,0.000026000464,0.00008877893,0.0000627873,0.00014916029],"domain_scores_gemma":[0.99779665,0.0014434928,0.00036588067,0.00004175029,0.0001604444,0.00019173548],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017315312,0.00058332266,0.00057545985,0.0006248072,0.00024341288,0.0014143371,0.00058247265,0.00063933094,0.0048354776],"category_scores_gemma":[0.0049479646,0.00041214048,0.0011973724,0.00057038147,0.00023027562,0.0007724329,0.0006892023,0.0008976211,0.00023625583],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010302599,0.00023814599,0.043140415,0.00016007067,0.00037067573,0.00023419128,0.000044719043,0.9365362,0.000349548,0.004535412,0.0016057685,0.011754542],"study_design_scores_gemma":[0.0004141621,0.00076270424,0.01832204,0.00013002641,0.00038436637,0.00022798225,0.00016947534,0.97088474,0.00047878313,0.0064396514,0.001751894,0.00003423005],"about_ca_topic_score_codex":0.013704732,"about_ca_topic_score_gemma":0.009507696,"teacher_disagreement_score":0.013704732,"about_ca_system_score_codex":0.0028652276,"about_ca_system_score_gemma":0.0027693901,"threshold_uncertainty_score":0.027249873},"labels":[],"label_agreement":null},{"id":"W4413833477","doi":"10.2147/ceor.s538395","title":"Beyond the COVID-19 Pandemic: Budget Impact Analysis of Remote Healthcare Delivery for Hypertension and Diabetes Mellitus Management in Thailand","year":2025,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Telemedicine and Telehealth Implementation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of Toronto","funders":"Thammasat University","keywords":"Pandemic; Medicine; Coronavirus disease 2019 (COVID-19); Diabetes mellitus; Healthcare delivery; Diabetes management; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); 2019-20 coronavirus outbreak; Health care; Telemedicine; Intensive care medicine; Virology; Internal medicine; Type 2 diabetes; Economic growth; Disease; Infectious disease (medical specialty); Outbreak","score_opus":0.1426317256737952,"score_gpt":0.5061215660319606,"score_spread":0.36348984035816534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413833477","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98906994,0.0017759937,0.0016498998,0.0010458351,0.000025600002,0.00018880966,0.0034063018,0.000014830875,0.0028227738],"genre_scores_gemma":[0.99675435,0.0007591273,0.0006954395,0.00007322655,0.00001557187,0.00008757411,0.0013007213,0.0000065367453,0.00030743208],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9973122,0.0015703976,0.00014999065,0.00015652139,0.0002999992,0.0005109479],"domain_scores_gemma":[0.9952916,0.0021885985,0.0012557226,0.000115080744,0.00068001164,0.0004689747],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030394502,0.0007733613,0.000515429,0.0019346201,0.00034401554,0.0018662616,0.00054106856,0.0005380187,0.002854108],"category_scores_gemma":[0.0076223244,0.00039061447,0.0016662738,0.0031526526,0.00046392265,0.0013937114,0.0013152236,0.0010849176,0.00010636302],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002531104,0.000699859,0.56694186,0.0014681963,0.0018986621,0.0024858057,0.000683087,0.38130057,0.0005813772,0.0052834605,0.0036521733,0.032473933],"study_design_scores_gemma":[0.0002924359,0.0017870401,0.63831955,0.0009802014,0.0012069166,0.0009470424,0.007873846,0.33747154,0.001073266,0.0035595354,0.0063055917,0.00018290887],"about_ca_topic_score_codex":0.060272522,"about_ca_topic_score_gemma":0.03353287,"teacher_disagreement_score":0.060272522,"about_ca_system_score_codex":0.007327626,"about_ca_system_score_gemma":0.004387633,"threshold_uncertainty_score":0.119843364},"labels":[],"label_agreement":null},{"id":"W4414096736","doi":"10.2147/ceor.s533069","title":"Determinants of Economic Costs Following Road Traffic Injuries in Canada: A Quantile Regression Forests Machine Learning Approach","year":2025,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Traffic and Road Safety","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre for Advancing Health Outcomes; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Quantile regression; Economic cost; Resource allocation; Road traffic; Quantile; Poison control; Resource (disambiguation); Economic model; Decision tree","score_opus":0.028497031037728705,"score_gpt":0.3532528931435239,"score_spread":0.3247558621057952,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414096736","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95792395,0.0019142587,0.027018594,0.0020686232,0.00005098929,0.00011179436,0.008839898,0.00022029251,0.0018516422],"genre_scores_gemma":[0.9907732,0.00034131875,0.004619909,0.0000781459,0.000018424158,0.000037029968,0.003452139,0.000020648526,0.0006592115],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992606,0.00022856006,0.000036442463,0.00015464307,0.00012030975,0.00019937815],"domain_scores_gemma":[0.996563,0.0015863397,0.00040336803,0.00018027979,0.0010747422,0.00019224279],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031187094,0.00055643375,0.0005608877,0.0021039604,0.0009082378,0.0011563419,0.0013383816,0.00048125023,0.0024045967],"category_scores_gemma":[0.0092466315,0.00029079337,0.0011548046,0.0022093053,0.0004751667,0.0004710482,0.0006378146,0.0012418099,0.00024058047],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016718081,0.00008876332,0.9073339,0.00008448364,0.0002626459,0.00016473292,0.00026163663,0.052780557,0.00012883494,0.0016552552,0.0037349449,0.033337023],"study_design_scores_gemma":[0.000018619958,0.00003548867,0.55324817,0.00010684342,0.00016051813,0.000092124465,0.00071977667,0.43928674,0.00015944449,0.0036397122,0.002496046,0.000036431087],"about_ca_topic_score_codex":0.85833955,"about_ca_topic_score_gemma":0.7610961,"teacher_disagreement_score":0.14166045,"about_ca_system_score_codex":0.005785351,"about_ca_system_score_gemma":0.0072929678,"threshold_uncertainty_score":0.28498942},"labels":[],"label_agreement":null},{"id":"W7115193744","doi":"10.2147/ceor.s546850","title":"Cost-Utility Analysis of Renal Replacement Therapy Modalities in the Management of Severe Acute Kidney Injury in US Critically Ill Patients","year":2025,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Acute Kidney Injury Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Renal replacement therapy; Acute kidney injury; Critically ill; Modalities; Therapeutic modalities; Treatment modality","score_opus":0.08317054389346228,"score_gpt":0.4737478615328139,"score_spread":0.3905773176393516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7115193744","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97562975,0.002781841,0.01233616,0.0016819205,0.000048514084,0.0005462959,0.0029758997,0.000048264013,0.00395146],"genre_scores_gemma":[0.996409,0.0003066747,0.0022635278,0.00008009676,0.0000109818575,0.00011411666,0.00056752417,0.000005768276,0.00024243451],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.99595624,0.0031179436,0.000150893,0.00021071524,0.00029283835,0.00027142253],"domain_scores_gemma":[0.9805549,0.016451234,0.0014092483,0.000315912,0.0008656794,0.000402968],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0074113053,0.00091592397,0.0010241546,0.0020614169,0.00035272012,0.0014779232,0.0012296279,0.0010366485,0.0029946323],"category_scores_gemma":[0.024292523,0.000551304,0.0029640533,0.0018192086,0.0005779003,0.00096851925,0.0011427102,0.00135272,0.0001305143],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017726019,0.00030342332,0.031199487,0.00029340613,0.0011249954,0.0001833004,0.00006356079,0.9523279,0.00018899134,0.0042523947,0.0007174291,0.007572504],"study_design_scores_gemma":[0.00023883552,0.000874586,0.016911685,0.00016183493,0.0007448014,0.00014469193,0.00013575202,0.9766149,0.00024600604,0.0032511752,0.00063543324,0.000040326257],"about_ca_topic_score_codex":0.022112072,"about_ca_topic_score_gemma":0.010019486,"teacher_disagreement_score":0.022112072,"about_ca_system_score_codex":0.006488466,"about_ca_system_score_gemma":0.0029561822,"threshold_uncertainty_score":0.047077358},"labels":[],"label_agreement":null},{"id":"W7116889275","doi":"10.2147/ceor.s567932","title":"Consequences of Canada’s Drug Agency Reimbursement Recommendations for New Medicines and Pan-Canadian Pharmaceutical Alliance Price Negotiations on Patient Access","year":2025,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Arthur B. McDonald-Canadian Astroparticle Physics Research Institute; Fraser Institute; Wilfrid Laurier University; Canadian Institute for Health Information","funders":"","keywords":"Reimbursement; Listing (finance); Government (linguistics); Negotiation; Agency (philosophy); Access to medicines; Alliance","score_opus":0.5671951713696002,"score_gpt":0.5952915884355787,"score_spread":0.02809641706597854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7116889275","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6739361,0.013276651,0.0015808662,0.12617381,0.0009352183,0.0006820548,0.021597186,0.00019390347,0.16162421],"genre_scores_gemma":[0.975832,0.0021865363,0.0016328164,0.012247018,0.0002893299,0.000111860885,0.0034270226,0.000034436773,0.0042389515],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.94149846,0.009140064,0.0047369283,0.002249428,0.03614657,0.006228689],"domain_scores_gemma":[0.83512896,0.057765488,0.052307356,0.0025890595,0.037813824,0.01439537],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.018608108,0.0002613602,0.00041431692,0.0019642445,0.0032654575,0.0047045886,0.0015686847,0.0020580217,0.0056582796],"category_scores_gemma":[0.10810221,0.00044836605,0.0012935929,0.003592778,0.0012339972,0.0009884344,0.0014617738,0.003067904,0.0003413577],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001855852,0.00031185025,0.68732613,0.00087594084,0.0006907334,0.0010282529,0.002499664,0.0050437017,0.0007287463,0.015657222,0.16159162,0.122390255],"study_design_scores_gemma":[0.0001466228,0.00015269335,0.92937225,0.0005232524,0.00015844409,0.0005630461,0.0014894257,0.00227634,0.00041833174,0.0007155307,0.064075634,0.00010844693],"about_ca_topic_score_codex":0.8764127,"about_ca_topic_score_gemma":0.9003594,"teacher_disagreement_score":0.94542485,"about_ca_system_score_codex":0.054575138,"about_ca_system_score_gemma":0.075489275,"threshold_uncertainty_score":0.3959722},"labels":[],"label_agreement":null}]}